name: Study of Salvage Therapy to Treat Patients with Granulomatosis with Polyangiitis

original_conditions: Anti-neutrophil Cytoplasmic Antibody-associated Vasculitis


clinical_trial_tested_intervention: unsure

clinical_trial_overall_status: COMPLETED

clinical_trial_enrollment_type: ESTIMATED

clinical_trial_age_range: 18 years or older

clinical_trial_primary_purpose: TREATMENT

name: Rituximab, Cladribine, and Temsirolimus in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma


clinical_trial_overall_status: RECRUITING

clinical_trial_intervention_model: SEQUENTIAL

name: BBO-11818 in Adult Subjects With KRAS Mutant Cancer

original_conditions:
NSCLC
Non-Small Cell Lung Cancer

original_conditions: Metastatic Pancreatic Ductal Adenocarcinoma


clinical_trial_tested_intervention: yes

clinical_trial_enrollment_type: ACTUAL

clinical_trial_age_range: 1 year to 5 years

clinical_trial_intervention_model: PARALLEL

name: Propofol to Reduce the Incidence of Postanesthetic Emergence Agitation in Pediatric Patients Under General Anesthesia


clinical_trial_overall_status: TERMINATED

name: Single Agent Decitabine in TP53 Mutated Relapsed/Refractory Acute Myeloid Leukemia


clinical_trial_age_range: 18 years to 65 years

name: Riluzole Effects on Hippocampus Biomarkers


name: Clinical Trial to Evaluate the Efficacy of Different Treatments in Patients With COVID-19


clinical_trial_age_range: 18 years to 75 years

name: Does Optimal Control of Pre-operative Chronic and Acute Pain Predict Improved Function After Orthopedic Surgery?


name: CAVE-2 GOIM Study: a Clinical Study of the Combination of Avelumab Plus Cetuximab as Rechallenge Strategy


clinical_trial_overall_status: UNKNOWN

clinical_trial_age_range: 18 months to 25 years

name: Phase I/II Trial of Everolimus in Combination With Lonafarnib in Progeria


name: A Phase II Study of Bevacizumab, Irinotecan and Capecitabine in Patients With Previously Untreated Metastatic Colorectal Cancer


clinical_trial_age_range: 40 years to 75 years

name: Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of NIO752 in Progressive Supranuclear Palsy


clinical_trial_age_range: 18 years to 80 years

name: How Vitamin D Analogues Affect Endothelial Cells in Patients on Dialysis


clinical_trial_age_range: 25 years to 80 years

name: Vascular and Metabolic Effects of Rosuvastatin


clinical_trial_overall_status: WITHDRAWN

name: Ulinastatin for the Treatment of COVID-19 in Hospitalized Patients


clinical_trial_age_range: 18 years to 99 years

name: Pain Management After Elective Shoulder Surgery


Trial of AEO in New Glioblastoma (GBM)

original_interventions:
AEO
Anhydrous Enol-Oxaloacetate


name: Study of Daratumumab Combined With Carfilzomib, Lenalidomide and Dexamethasone for Newly Diagnosed Multiple Myeloma


clinical_trial_age_range: 1 year to 12 years

clinical_trial_primary_purpose: SCREENING

name: Epigenetics in PostOperative Pediatric Emergence Delirium


clinical_trial_age_range: 25 years to 65 years

name: Nebivolol Effects on Endothelial Function and Erectile Function


clinical_trial_age_range: 19 years or older

name: Decitabine and Selinexor in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia


clinical_trial_age_range: any age

name: A Study to Assess Two Different Strategies of Combining Dexamethasone and VELCADE


name: Ramucirumab Plus Pembrolizumab vs Usual Care for Treatment of Stage IV or Recurrent Non-Small Cell Lung Cancer Following Immunotherapy, Pragmatica-Lung Study


clinical_trial_intervention_model: FACTORIAL

name: Hydroxychloroquine and Lopinavir/ Ritonavir to Improve the Health of People With COVID-19: The Hope Coalition - 1


name: GLP-1 Loading During Elective Percutaneous Coronary Intervention


name: Thyroid Disease in Pregnancy: Case Finding Versus Universal Screening


name: Phase I Trial of 225Ac-J591 in Patients With mCRPC


clinical_trial_primary_purpose: PREVENTION

name: Immunogenicity and Safety Study of the 3rd Booster Dose Using the High or Medium Dose of Inactivated Vaccine in Healthy Adults in in Hong Kong


name: Evaluating Benzoyl Peroxide for Preventing Recurrence of HSV-1 Outbreaks With Rescue Crossover Option


clinical_trial_age_range: 60 years to 83 years

name: Effects of Chocolate Consumption in Elderly Patients With Cancer in Palliative Care


clinical_trial_age_range: 12 years or older

name: 6-TG, Capecitabine and Celecoxib Plus TMZ or CCNU for Anaplastic Glioma Patients

original_interventions: Celebrex Celecoxib


name: A Study of Intravenous or Subcutaneous Methoxy Polyethylene Glycol-Epoetin Beta (RO0503821, Mircera) in Chronic Kidney Disease Patients With Renal Anemia


name: A Study to Evaluate the Safety and Tolerability of SAGE-718 in Participants With Huntington's Disease


name: Efficacy And Safety Of PF-00885706 For The Relief Of Symptoms In Subjects With Gastro-esophageal Reflux Disease (GERD)


name: Neoadjuvant Nivolumab with CCR2/5-inhibitor or Anti-IL-8) for Non-small Cell Lung Cancer (NSCLC) or Hepatocellular Carcinoma (HCC)


name: Cyclophosphamide Therapy for Refractory Antibody-Mediated Rejection (AMR) in Kidney Transplants


clinical_trial_age_range: 12 years to 18 years

name: Pregabalin In Adolescent Patients With Fibromyalgia


clinical_trial_age_range: 18 years to 70 years

name: Apatinib Dose Titration in Advanced or Metastatic Gastric Cancer


clinical_trial_time_perspective: RETROSPECTIVE

name: Use of Clonidine to Prevent Withdrawal Following Prolonged Dexmedetomidine Infusions


clinical_trial_age_range: 12 years to 65 years

name: Three Types of Nucleotide/Nucleoside Analogues Treatment in HBV Related ACLF


clinical_trial_age_range: 12 years to 16 years

name: Iron Sucrose in Non-Dialysis Dependent (NDD-CKD) Pediatric Patients


Memantine for Recurrent Glioblastoma

clinical_trial_age_range: 18 years or older


clinical_trial_age_range: 18 years to 75 years

name: Paclitaxel in Treating Patients With Refractory or Recurrent Acute Leukemia or Chronic Myelogenous Leukemia


name: Study of ARO-ANG3 in Healthy Volunteers and in Dyslipidemic Patients


clinical_trial_age_range: 18 years to 50 years

name: Evaluating the Safety and Immunogenicity of Env (A,B,C,A/E)/Gag (C) DNA and gp120 (A,B,C,A/E) Protein/GLA-SE HIV Vaccines, Given Individually or Co-administered, in Healthy, HIV-1-Uninfected Adults


name: Comparison of Two Different Dosages of Low-molecular Weight Heparin in Cancer Patients


name: The Role of Quadratus Lumborum Blocks Following Minimally Invasive Hysterectomy


name: Angiotensin II Antagonist in Severe Sepsis


name: OH2 Oncolytic Viral Therapy in Solid Tumors


name: A Study of SKB264 Versus Investigator's Choice of Chemotherapy in Subjects With Unresectable Locally Advanced, Relapsed, or Metastatic HR+/HER2- Breast Cancer Who Have Previously Failed Endocrine Therapy


name: Concurrent Oxytocin With Membrane Sweeping Versus Dinoprostone Pessary in Labor Induction of Nulliparas at Term


clinical_trial_age_range: 10 years to 20 years

name: Insulin Resistance, Polycystic Ovary Syndrome, and Bone Research Study


clinical_trial_age_range: 50 years or older

clinical_trial_primary_purpose: DIAGNOSTIC

name: A Phase II Trial of 18F-AV-45 Positron Emission Tomography (PET) Imaging in Healthy Volunteers, Patients With Mild Cognitive Impairment (MCI) and Patients With Alzheimer's Disease (AD)


name: Desmopressin as Treatment for Postoperative Bleeding After Cardiac Surgery


name: Efficacy of Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes Failing on OADs

original_conditions:
Diabetes
Diabetes Mellitus, Type 2


clinical_trial_age_range: 40 years or older

name: Bicalutamide and Raloxifene Hydrochloride in Treating Patients With Prostate Cancer Undergoing Surgery


clinical_trial_age_range: 8 years to 17 years

name: Study Evaluating Tigecycline Versus Ceftriaxone In Complicated Intra-Abdominal Infections & Community Acquired Pneumonia


name: Study to Measure Drug Satisfaction of Patients With Schizophrenia After Switching From Risperidone to Paliperidone


clinical_trial_age_range: 18 years to 49 years

name: A Clinical Study to Evaluate the Safety and Efficacy of Elagolix in Participants With Moderate to Severe Endometriosis-Associated Pain


clinical_trial_age_range: 18 years to 99 years

name: Safety and Efficacy of Evolocumab in Addition to Optimal Stable Background Statin Therapy in Chinese Participants With Primary Hypercholesterolemia and Mixed Dyslipidemia


clinical_trial_age_range: 18 years to 65 years

name: Comparison of Intra-articular Dexmedetomidine and Magnesium in Postoperative Pain


name: MLN0264 in Previously Treated Asian Participants With Advanced Gastrointestinal Carcinoma or Metastatic or Recurrent Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Guanylyl Cyclase C

original_conditions: Metastatic Gastroesophageal Junction Adenocarcinoma

original_conditions: Recurrent Gastroesophageal Junction Adenocarcinoma


name: Phase 2/Phase 3 Study To Evaluate The Efficacy And Safety Of Ramatroban Along With The Standard Of Care In Subjects Hospitalized For COVID Pneumonia


name: Efficacy and Safety of BG2109 in Chinese Subjects With Endometriosis


name: Photodynamic Therapy With HPPH Compared to Standard of Care Surgery in Treating Patients With Oral Cavity Cancer

original_conditions: Stage I Oral Cavity Squamous Cell Carcinoma

original_conditions: Stage II Oral Cavity Squamous Cell Carcinoma


clinical_trial_age_range: 18 years to 90 years

name: Impact of the Addition of Metformin to Abiraterone in Metastatic Prostate Cancer Patients


name: Study of the Oral Factor D (FD) Inhibitor ALXN2050 in PNH Patients as Monotherapy

original_conditions: Paroxysmal Nocturnal Hemoglobinuria (PNH)


name: Detecting Occult HBV Infection in Liver Donors Positive for Antibody to Hepatitis B Core Antigen (Anti-HBc)


clinical_trial_age_range: 18 years to 60 years

clinical_trial_time_perspective: PROSPECTIVE

name: Small Volume Fluid Challenge as a Predictor of Fluid Responsiveness in Patients With Circulatory Failure


name: Furosemide Alone or Unexpectedly With Solution of Hypertonic Saline in Nephrotic Syndrome


clinical_trial_age_range: 18 years to 85 years

name: Intrathecal Morphine and Local Infiltration Analgesia in Total Knee Arthroplasty


name: Growth Hormone Releasing Hormone Analog to Improve Nonalcoholic Fatty Liver Disease and Associated Cardiovascular Risk

original_conditions:
Fatty Liver
Liver Fat


clinical_trial_age_range: 12 years or older

name: Safety and Efficacy of Nyxol (0.75% Phentolamine Ophthalmic Solution) to Reverse Pharmacologically-Induced Mydriasis


name: RAMucirumab in Combination Wth TAS102 vs. TAS102 Alone in Chemotherapy Refractory Metastatic Colorectal Cancer Patients


name: Canakinumab for the Prevention of Lung Cancer, the Can-Prevent-Lung Trial


clinical_trial_age_range: 1 year to 70 years

name: Nucleoside Therapy in Patients With Telomere Biology Disorders


name: Effect of Darapladib on Cantharidin-Induced Inflammatory Blisters in Subjects With Type 2 Diabetes Mellitus (T2DM)


clinical_trial_age_range: 40 years to 78 years

name: Perampanel for Sporadic Amyotrophic Lateral Sclerosis (ALS)


name: Phase I/Ib Study of GWN323 Alone and in Combination With PDR001 in Patients With Advanced Malignancies and Lymphomas


clinical_trial_age_range: 20 years or older

name: Valemetostat Tosylate (DS-3201b) Phase 2 Study in Relapsed or Refractory Adult T-cell Leukemia/Lymphoma


clinical_trial_age_range: 18 years or older

name: Dapagliflozin and Effect on Cardiovascular Events in Acute Heart Failure -Thrombolysis in Myocardial Infarction 68 (DAPA ACT HF-TIMI 68)


clinical_trial_age_range: 60 years or older

name: ZOSTAVAX™ Administered Concomitantly With PNEUMOVAX™ 23 (V211-012)(COMPLETED)


clinical_trial_age_range: 13 years to 17 years

clinical_trial_primary_purpose: OTHER

name: Vyvanse Adolescent Open-Label Safety and Efficacy Extension Study


clinical_trial_age_range: 23 years to 72 years

clinical_trial_intervention_model: CROSSOVER

name: Study to Evaluate the Safety and Efficacy of Dietary Supplement Anatabloc in Reducing Daily Smokers' Urge to Smoke


name: Flavopiridol, Cytarabine, and Mitoxantrone in Treating Patients With Relapsed or Refractory Acute Leukemia

original_conditions: Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)

original_conditions: Adult Acute Megakaryoblastic Leukemia (M7)

original_conditions: Recurrent Adult Acute Lymphoblastic Leukemia

original_conditions: Adult Acute Myeloblastic Leukemia Without Maturation (M1)

original_conditions: Adult Acute Myeloblastic Leukemia With Maturation (M2)

original_conditions: Adult Acute Myelomonocytic Leukemia (M4)

original_conditions: Adult Acute Minimally Differentiated Myeloid Leukemia (M0)

original_conditions: Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)

original_conditions: Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)

original_conditions: Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities


name: Phase II Study of Immunization With a Hepatitis C Virus (HCV) Antigen Peptide Vaccine


name: First Time in Human Study of Intravenous Interleukin-18 Antibody


clinical_trial_age_range: 4 years to 18 years

name: Prospective Trial Comparing Oxybutynin and Tamsulosin for Stent Pain in the Pediatric Population


clinical_trial_age_range: 18 years to 55 years

name: Fruquintinib Food Effect and Proton Pump Inhibitor Study


name: Can a Nasal Decongestant Test Predict Treatment Outcomes in Seasonal Allergic Rhinitis?


clinical_trial_age_range: 18 years to 80 years

name: Methocarbamol vs Oxybutynin for Management of Pain and Discomfort S/P Ureteroscopy Procedure


name: A Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Non-cystic Fibrosis Bronchiectasis


name: Acute Effects of Cortisol on Heroin Craving in Opioid Dependence (Ghost-Basel)


name: Testing a New Chemotherapy Drug, KRT-232 (AMG-232) in Combination With Decitabine and Venetoclax in Patients With Acute Myeloid Leukemia


name: Study of Roxadustat in the Treatment of Acute Myocardial Infarction


name: Early Use of Corticosteroids in Non-critical Patients With COVID-19 Pneumonia


name: Dideoxycytidine ( Ro 24-2027 ). A Treatment Protocol for the Use of Dideoxycytidine ( ddC ) in Patients With AIDS or Advanced ARC Who Cannot Be Maintained on Zidovudine ( AZT ) Therapy.


clinical_trial_age_range: 19 years or older

name: Lenvatinib After Progression on Atezolizumab-bevacizumab in Hepatocellular Carcinoma


name: The Farnesoid X Receptor (FXR) Ligand Obeticholic Acid in NASH Treatment Trial(FLINT)

original_conditions: Nonalcoholic Fatty Liver Disease (NAFLD)


clinical_trial_age_range: 18 years to 100 years

name: Clinical Trial for the Evaluation of Melatonin in the Treatment of Pressure Ulcers


name: Radiation + Cisplatin or Panitumumab in Locally Advanced Stage III or Stage IV Head and Neck Cancer


clinical_trial_age_range: 18 years to 120 years

name: Tadalafil in Preventing Erectile Dysfunction in Patients With Prostate Cancer Treated With Radiation Therapy


clinical_trial_age_range: 18 years to 99 years

name: Imaging Study for FdCyd and THU Cancer Treatment


name: Dexamethasone and Functional Outcome After TKA


clinical_trial_age_range: 18 years to 65 years

name: A 52-Week Open-Label Safety Study of PD 0332334 in Subjects With Generalized Anxiety Disorder (GAD)


clinical_trial_age_range: 18 years to 75 years

name: Study of Vitamin D and Uric Acid Lowering on Kidney and Blood Vessel Function


name: Zometa Adjuvant Treatment of Malignant Pleural Effusion Due To Non-Small Cell Lung Cancer


name: Study of Initial Treatment With Elotuzumab, Carfilzomib, Lenalidomide and Dexamethasone in Multiple Myeloma


clinical_trial_age_range: any age

name: Validation Study of a cOmputer Pharmacokinetic Tool to assIst in the Follow up Care of haeMophilia A Patients


clinical_trial_age_range: 55 years to 95 years

name: Olfactory Deficits and Donepezil Treatment in Cognitively Impaired Elderly

original_conditions: Delirium, Dementia, Amnestic, Cognitive Disorders


name: Pembrolizumab After Radiation Therapy and Chemotherapy in Limited Stage Small Cell Lung Cancer


name: SB-4826 in Adult Participants With Locally Advanced or Metastatic Solid Tumors or Non-Hodgkin Lymphomas


clinical_trial_age_range: 6 years to 18 years

name: BIFI-OBESE: Clinical Trial in Paediatric Obesity


clinical_trial_age_range: 18 years to 70 years

name: Pharmacological Treatment of Comorbid Alcohol and Marijuana Withdrawal and Dependence

original_conditions:
Alcohol Dependence
Alcohol Use Disorder


name: Immunogenicity and Safety of GBS-NN/NN2 in Pregnant Women


name: Special Drug Use Surveillance on Long-term Use of Sodium Risedronate Tablets (Benet 75 mg Tablets) (12-month Treatment Survey)


clinical_trial_age_range: 18 years or older

name: WILL lOWer Dose Aspirin be Better With Rivaroxaban in Patients With Chronic Coronary Syndromes?


clinical_trial_age_range: 13 years or older

name: Antibiotics as an Adjuvant in Patients With Acute Severe Ulcerative Colitis


clinical_trial_age_range: 18 years to 60 years

name: The Influence of Intra-alveolar Application of Honey on Healing Following Extraction


name: TMC125-TiDP2-C197: A Phase I Trial to Investigate the Pharmacokinetic Interaction Between Lopinavir/Ritonavir and TMC125 Both at Steady-state in Healthy Volunteers.


name: Evaluation of Dose-titration of Pramlintide During Initiation of Therapy in Patients Trying to Improve Glucose Control


name: A Phase I Study of SH003 for Evaluate Safe Dose Range in Patients With Solid Cancer


Evolocumab in Patients With Acute MI

clinical_trial_age_range: 25 years to 90 years


name: Phosphodiesterase Inhibitors, Pentoxifylline, as Adjunctive Therapy in Patients With Ulcerative Colitis.


name: RN624 For Pain Of Post-Herpetic Neuralgia


name: A Study Assessing if it is Safe and Possible to Treat Brain Cancer Patients With Immunotherapy Before They Receive the Standard Treatment.


clinical_trial_age_range: 20 years to 50 years

name: Histamine Receptor 2 Antagonists as Enhancers of Anti-Tumour Immunity


clinical_trial_age_range: 21 years to 99 years

name: Research on Infarction With Open Arteries Using OCT and CMR


clinical_trial_age_range: 21 years to 75 years

name: A Study of the Effect of Polyphenon E (Green Tea Extract) on Breast Cancer Progression


clinical_trial_age_range: 25 years to 80 years

name: Pregabalin as an add-on Therapy to Carbamazepine in Trigeminal Neuralgia Patients


clinical_trial_age_range: 18 years to 50 years

name: Posterior Tibia Nerve Neuroprolotherapy for Dysmenorrhea


clinical_trial_age_range: 21 years to 45 years

name: Phase 3 Clinical Trial: D-methionine to Reduce Noise-Induced Hearing Loss (NIHL)


name: A Study of Neoadjuvant Bio-C/T Followed by Concurrent Bio-R/T in High-risk Locally Advanced Oral Squamous Cell Carcinoma


name: SGLT2 Inhibitors and Survival in Lung Cancer Patients With Diabetes


clinical_trial_age_range: 40 years to 75 years

name: Study of Cilostazol and Probucol to Assess Their Effects on Atherosclerosis Related Biomarker


name: Eribulin Mesylate in Treating Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy


name: Clinical Trial to Optimise Levels of Vitamin D for Rhinovirus Protection


clinical_trial_age_range: 18 years to 35 years

name: The Effect of Small Changes in Hydration on Cognition


name: Efficacy and Safety of Lucentis for Clinically Significant Macular Edema Secondary to Central Retinal Vein Occlusion


clinical_trial_age_range: 45 years or older

name: New Biomarker for Alzheimer's Disease Diagnostic


clinical_trial_age_range: 5 years to 17 years

name: Childhood Hypertonia of Central Origin: A Trial of Anticholinergic Treatment Effects


clinical_trial_age_range: 35 years to 55 years

name: A Comparative Study of Adapalene Gel,0.3% Versus Tretinoin Emollient Cream, 0.05% for the Treatment of Photoaging


clinical_trial_age_range: 50 years to 85 years

name: KPL-301 for Subjects With Giant Cell Arteritis


name: The Effects of Moderate vs. Aggressive Treatment With Valsartan + Amlodipine on Patients With Hypertension Uncontrolled by Angiotensin-Receptor Blocker (Herein, ARB) Monotherapy


clinical_trial_age_range: 15 years to 40 years

name: Comparative Study Between Treatment With Cryotherapy Alone Versus Cryotherapy Plus Salicylic Acid Dressing for Planter Warts


clinical_trial_age_range: 18 years or older

name: 5-Fluoro-2'-Deoxcyctidine and Tetrahydrouridine to Treat Patients With Advanced Cancer

original_interventions: THU Tetrahydrouridine


clinical_trial_age_range: 18 years to 120 years

name: Vaccine Therapy and GM-CSF in Treating Patients With CNS Lymphoma

original_interventions: autologous immunoglobulin idiotype-KLH conjugate vaccine


name: A Study to Evaluate Efficacy, Safety & Pharmacokinetics of the Port Delivery System (PDS) With Ranibizumab in Participants With Diabetic Macular Edema (DME) Compared With Intravitreal Ranibizumab; A Substudy to Evaluate the Safety of Re-implanting the PDS With Ranibizumab in Participants With DME


name: PORH and Response to Cold in Raynaud's Phenomenon.


name: Carboplatin, Paclitaxel, Bevacizumab and Vorinostat for Patients With Advanced Non-Small Cell Lung Cancer


clinical_trial_age_range: 1 day to 12 months

name: Nitrogen Balance in Infants After Post Cardiothoracic Surgery


name: PRELUDE:Study to Investigate the Prevention of Relapse in Lymphoma Using Daily Enzastaurin


clinical_trial_age_range: 18 years to 60 years

name: Treatment Strategy for Low-grade Gliomas


name: A Safety Study Comparing Natrecor (Nesiritide) Versus Dobutamine Therapy for Worsening Congestive Heart Failure


clinical_trial_age_range: 18 years to 55 years

name: Study Assessing the Safety, Tolerability, and Pharmacokinetics of SEP-363856 in Male and Female Subjects With Schizophrenia


clinical_trial_age_range: 18 years to 100 years

name: Sacubitril/Valsartan in Heart Failure With Reduced Ejection Fraction Patients: a Real World Study in India


name: Guadecitabine in Treating Patients With Higher-Risk Myelodysplastic Syndromes


clinical_trial_overall_status: SUSPENDED

clinical_trial_age_range: 2 years to 14 years

name: Normal Saline Versus Heparinized Solution Flush for Maintaining Patency of Peripheral Venous Catheters in Children

original_conditions: Extravasation of Diagnostic and Therapeutic Materials


name: Celecoxib to Prevent Cancer in Patients With Barrett's Esophagus


clinical_trial_age_range: 18 years to 65 years

name: Pre-operative Pregabalin and Ketamine to Prevent Phantom Pain


name: Pembrolizumab as Neoadjuvant Therapy for Resectable Stage IA3 to IIA Non-Small Cell Lung Cancer (NSCLC)


clinical_trial_age_range: 20 years to 80 years

name: Phase 3 Study to Evaluate the Efficacy and Safety of Droxidopa on Orthostatic Hypotension Treatment in Hemodialysis Patients


clinical_trial_age_range: 18 years to 50 years

name: Pharmacokinetics and Metabolism Study in Healthy Male Participants


clinical_trial_age_range: any age

name: Treatment Modalities of Oral Lichen Planus


clinical_trial_age_range: 45 years to 75 years

name: Safety Study of Erythropoietin (EPO) in Parkinson's Disease


clinical_trial_age_range: 50 years or older

name: Primary Prevention of Major Adverse Cardiac Events (MACE) With Standard and Intensive Statin Treatment in Patients With Diabetes: Survival and Cardiovascular Event Assessments


name: Carboplatin, Docetaxel, and Radiation Therapy in Treating Patients With Stage III/IV, or Recurrent Endometrial Cancer


name: Phase II Part 2 Expansion of Oral Rigosertib in Combination With Azacitidine


clinical_trial_age_range: 18 years to 45 years

name: A Study to Investigate the Effect of ONO-8539 on Acid-Induced Oesophageal Hypersensitivity in Healthy Volunteers


name: Safety and Efficacy of GTS21 in Adults With Attention-deficit Hyperactivity Disorder

original_conditions: Attention Deficit Hyperactivity Disorder


clinical_trial_age_range: 18 years to 70 years

name: Reduction of MTX Levels After Glucarpidase Treatment in DLBCL Patients at Risk of CNS


name: Safety and Pharmacokinetic Study of Hepalatide(L47) in Healthy Volunteers


name: Metronidazole as Preoperative Therapy in CRC / FusoMetro-001


name: Proof-of-concept Study Evaluating Subcutaneous Amlitelimab in Adult Participants With Moderate to Severe Hidradenitis Suppurativa


clinical_trial_age_range: 2 years to 18 years

name: Prospective Study of Benznidazole for Chagas' Disease Children With Chronic Indeterminate Chagas Disease


name: Bortezomib and Low Dose Cytarabine in the Treatment of High-risk Myelodysplastic Syndromes


name: Extended Follow-up of Patients With Macular Edema Due to Retinal Vein Occlusion


name: Effect of Furosemide on ESWL Outcomes for Renal and Ureteral Calculi


clinical_trial_age_range: 12 years to 75 years

name: Inotuzumab Ozogamicin and Chemotherapy in Treating Patients With Leukemia or Lymphoma Undergoing Stem Cell Transplantation

original_conditions:
Lymphocytic Neoplasm
Lymphoma


clinical_trial_age_range: 18 years or older

name: Temodar and Sutent as Therapy for Melanoma


clinical_trial_age_range: 18 years to 35 years

name: Effect of Hyoscine and Promethazine on Labor Pain


clinical_trial_age_range: 6 years to 15 years

name: Efficiency of IV Dexamethasone, Administered After a Lower Limb Blockade, on the Post Operative Pain in Children


clinical_trial_age_range: 18 years to 120 years

name: S0715: Acetyl-L-Carnitine in Preventing Neuropathy in Women With Stage I, II, or IIIA Breast Cancer Undergoing Chemo


clinical_trial_age_range: 21 years or older

name: Pilot Study of Varenicline to Treat Opioid Dependence


clinical_trial_age_range: 18 years to 60 years

name: Safety and Efficacy of AIV001 on Scar Formation and Keloid Recurrence Following Keloidectomy


name: Comparison of Two Combination Chemotherapy Regimens in Treating Adults With Previously Untreated Leukemia or Lymphoma


name: Grazoprevir and Elbasvir Without Ribavirin for 12 Weeks in Patients With HCV-related Cryoglobulinemic Nephropathy


name: A Study of Pemetrexed and Gefitinib Versus Gefitinib in Non-Small Cell Lung Cancer (NSCLC)


name: Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7


clinical_trial_age_range: 20 years or older

name: A Phase II, Single-Arm Trial of Poziotinib as Salvage Treatment in Patients With Metastatic Breast Cancer Who Has HER2 or EGFR Mutation or Activated AR or EGFR Pathway


name: A Follow up Study of Patients Treated With Imlifidase Prior to Kidney Transplantation


clinical_trial_age_range: 18 years to 65 years

name: Ziprasidone Augmentation of SSRIs for Patients With Major Depressive Disorder (MDD) That do Not Sufficiently Respond to Treatment With SSRIs


name: Phase 2 Anastrozole and Vandetanib (ZD6474) in Neoadjuvant Treatment of Postmenopausal Hormone Receptor-Positive Breast Cancer


clinical_trial_age_range: 21 years to 60 years

name: Gender Differences in Response to Nicotine Replacement Therapy and De-Nicotinized Cigarettes


clinical_trial_age_range: 18 years to 75 years

name: Combination of Chemotherapy Plus RT and SHR-1210 to Treat Patients With ESCC


name: To Assess the Anti-anginal Safety and Efficacy of Ivabradine in Subjects With Stable，Symptomatic Chronic Angina


name: Bendamustine in Combination With Rituximab as a First-line Therapy Followed by Maintenance Therapy With Rituximab in Patients With Follicular Lymphoma


clinical_trial_age_range: 18 years to 40 years

name: Bioavailability and Food Effect Study of Gelatin Formulation and Immediate Release Tablet Formulation of Afuresertib


name: Study of Adaptive Immunotherapy With VEGFR-TKI in Patients With Advanced RCC

original_conditions:
Clear Cell Renal Cell Carcinoma
Renal Cell Carcinoma


name: Phase 2 Study to Assess the Efficacy & Safety of Gemcitabine + Nab Paclitaxel With or Without Dociparstat in Metastatic Pancreatic Cancer Patients


name: A Study on the Safety and Efficacy of LAE001 in the Treatment of Metastatic Prostate Cancer


clinical_trial_age_range: 21 years to 80 years

name: Phase II Study to Assess the Efficacy of ASLAN001 Plus Capecitabine in CNS Metastases for HER2+ Breast Cancer


name: Early Phase Administration of Anakinra as a Rescue Treatment for Inhaled Allergen Challenge-Induced Airway Inflammation


clinical_trial_age_range: 16 years or older

name: A Study of Maribavir Compared to Valganciclovir to Treat Cytomegalovirus Infections in People Who Have Received Stem Cell Transplants


clinical_trial_age_range: 12 years or older

name: A Study of Long-Term Safety and Efficacy of Lanadelumab for Prevention of Acute Attacks of Non-histaminergic Angioedema With Normal C1-Inhibitor


name: First-in-Human Study to Evaluate AMG 579 in Healthy Subjects and Patients With Stable Schizophrenia


name: Zileuton in Preventing Lung Cancer in Patients With Bronchial Dysplasia


name: Priming Immunotherapy in Advanced Disease With Radiation

original_conditions: Squamous Cell Carcinoma of the Head and Neck


clinical_trial_age_range: up to 60 years

name: Combination Chemotherapy With or Without Colony-stimulating Factors in Treating Women With Breast Cancer


name: A Study of the Efficacy and Safety of Topiramate in the Treatment of Patients With Epilepsy.

original_conditions: Epilepsy Seizures


name: A Pilot Study to Assess Changes in Tumor Biology Following Second-line Treatment With Pembrolizumab Plus Lenvatinib in Patients With Advanced Pancreatic Ductal Adenocarcinoma


clinical_trial_age_range: 18 years to 79 years

name: Pilot Study of Treatment for Subclinical AMR (Antibody-mediated Rejection) in Kidney Transplant Recipients

original_interventions: Tacrolimus Extended Release Oral Tablet [Envarsus]


clinical_trial_age_range: up to 15 years

name: Excessive Crying in Children With Cerebral Palsy and Communication Deficits


clinical_trial_age_range: 12 years to 18 years

name: Influence of Vitamin D on Vascular Function in Adolescents and Young Adults With Type 1 Diabetes


clinical_trial_age_range: 3 years to 18 years

name: Effects of Traditional Chinese Medicine (GSJYF) in Children With Inherited Proteinuric Kidney Disease


clinical_trial_age_range: 14 years or older

name: The Efficacy of Triple Regimen in Newly Diagnosed AML Patients With FLT3 Mutation


clinical_trial_age_range: 18 years to 70 years

name: Efficacy and Safety of Basal Insulin Glargine Combination With Exenatide Bid vs Aspart30 in T2DM


clinical_trial_age_range: 18 years to 100 years

name: Study of Betaferon Adherence in Patients With Multiple Sclerosis Treated With Interferon Beta-1b


clinical_trial_age_range: 18 years or older

name: Phase II Study of Pazopanib as Second-line Treatment After Sunitinib in mRCC Patients


name: Palbociclib in Estrogen Receptor Positive (ER+) Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer

original_interventions:
Palbociclib
Palbociclib 100mg
Palbociclib 125mg
Palbociclib 75mg


name: Anti-GPC3 CAR T for Recurrent or Refractory Lung Squamous Cell Carcinoma


clinical_trial_age_range: 21 years to 65 years

name: Clinical Trial on Ladarixin Adjunctive Therapy to Improve Glycemic Control in Type 1 Diabetes.


name: A Study to Assess the Safety and Tolerability of BMS-986158 Alone and in Combination With Either Ruxolitinib or Fedratinib in Participants With Blood Cancer (Myelofibrosis)


name: A Study of Nipocalimab in Adult Participants With Active Lupus Nephritis


name: Lung Cancer With Copanlisib and Durvalumab


clinical_trial_age_range: 18 years to 85 years

name: Drug-Drug Interaction Study of Entinostat and Exemestane in Postmenopausal Women With ER+ Breast Cancer

original_conditions: Estrogen Receptor Positive Breast Cancer


clinical_trial_age_range: 24 years to 99 years

name: Duloxetine Impact on Postoperative Pain Control and Outcomes

original_conditions:
Narcotic Use
Opioid Use


clinical_trial_age_range: 18 years to 75 years

name: Toripalimab Combined With Apatinib Mesylate for the Treatment of Gastric Adenocarcinoma in a Prospective Randomized Multicenter Phase II Clinical Study


name: Safety Study of IL-21/Ipilimumab Combination in the Treatment of Melanoma


clinical_trial_age_range: 18 years to 55 years

name: Development of Human Laboratory Study Model of Cocaine Relapse Prevention II - 1


clinical_trial_age_range: 0 months to 65 years

clinical_trial_time_perspective: OTHER

name: Registry Study of Revcovi Treatment in Patients With ADA-SCID

original_conditions: Adenosine Deaminase Severe Combined Immunodeficiency


clinical_trial_age_range: 18 years to 80 years

name: A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH

original_conditions: MASH - Metabolic Dysfunction-Associated Steatohepatitis


name: Intratympanic Injection for Autoimmune Inner Ear Disease


clinical_trial_overall_status: AVAILABLE

clinical_trial_age_range: 12 years or older

name: Expanded Access: Mino-Lok Therapy (MLT) for the Treatment of CRBSI/CLABSI


name: Vitamin K Antagonist Versus Direct Oral Anticoagulant Treatments in Hemophilia


clinical_trial_age_range: 19 years or older

name: Lenalidomide for Advanced Hepatocellular Cancer:A Phase II Trial


name: Docetaxel and Lapatinib in Metastatic Transitional Cell Carcinoma in Bladder

original_conditions: Transitional Cell Carcinoma of the Bladder


name: Daptomycin Versus Placebo in Patients With Neutropenia and Fever


name: Program for Pembrolizumab (MK-3475) in Participants With Metastatic Melanoma Who Have Failed Standard of Care Therapy Including Ipilimumab (MK-3475-030)


name: Effect of Ranolazine on Gastrointestinal Motor Function and Pain in Patients With IBS-D

original_conditions: Diarrhea Predominant Irritable Bowel Syndrome


name: A Study of Selicrelumab (RO7009789) in Combination With Atezolizumab in Participants With Locally Advanced and/or Metastatic Solid Tumors


name: Effect of IMN1207 Versus Casein on Weight Loss, Survival and Quality of Life in Non-small Cell Lung Cancer Patients


name: Efficacy and Safety of Ursodeoxycholic Acid in Reversing Gastric Intestinal Metaplasia


name: 131Iodine-Tenatumomab Treatment in Tenascin-C Positive Cancer Patients


name: Curcumin Supplementation as an Add on Treatment for Patients With Inflammatory Bowel Diseases Treated With Vedolizumab


clinical_trial_age_range: 20 years or older

name: An Open Study of ASP8273 in Patients With Non-Small-Cell Lung Cancer (NSCLC) Who Have Epidermal Growth Factor Receptor (EGFR) Mutations


name: PQR309 and Eribulin in Metastatic HER2 Negative and Triple-negative Breast Cancer (PIQHASSO)


name: Phase I Study of Milatuzumab for Graft Versus Host Disease


clinical_trial_age_range: 1 day to 18 years

name: Dose Individualization of Antineoplastic Drugs and Anti-Infective Drug in Children With Hematoplastic Disease


name: Lenvatinib Combined Pembrolizumab in Advanced Hepatobiliary Tumors


name: Phase II Gleevec Idiopathic Hypereosinophilic Syndrome

original_conditions:
Eosinophilia
Hypereosinophilic Syndrome


name: Colchicine in Acutely Decompensated HFREF

original_conditions: Heart Failure With Reduced Ejection Fraction


name: Implitapide in Patients With Heterozygous Familial Hypercholesterolemia (HeFH) on Maximal Concurrent Lipid-Lowering Therapy


name: A Study to Determine the Efficacy and Safety of Albiglutide as Compared With Liraglutide.


clinical_trial_age_range: 14 years to 21 years

name: N-Acetylcysteine for Youth Cannabis Use Disorder


clinical_trial_age_range: 7 years to 11 years

name: Safety Study of Escitalopram in Children 7 to 11 Years of Age With Major Depressive Disorder


clinical_trial_age_range: 18 years to 33 years

name: Effect of Carbohydrate Consumption on Fatigue and Muscle Damage in Jiu-Jitsu Athletes


name: Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.


name: An Open-Label, Non-Comparative, Phase III Study of the Raf-Kinase Inhibitor BAY 43-9006 as a Subsequent to First-Line Therapy in Patients With Advanced Renal Cell Carcinoma

original_interventions: Nexavar Sorafenib


name: An Observational Study of the Mean Duration of Trastuzumab (Herceptin) Treatment in Participants With Early or Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer


name: Safety of OFS Combined With AI Endocrine Therapy in Chinese Premenopausal Breast Cancer Patients


clinical_trial_age_range: 18 years to 60 years

name: Effect Of Calcitriol On Neutrophil To Lymphocytes Ratio And High Sensitivity C-Reactive Protein Covid-19 Patients


name: Immunogenicity and Safety of Heterologous and Homologous Boosting With ChAdOx1-S and CoronaVac or a Formulation of SCB-2019 (COVID-19)


clinical_trial_age_range: 1 hour to 3 days

name: Effect of Enteral Bovine Lactoferrin in Preterm Infants


name: Atorvastatin Plus Ezetimibe on Coronary Plaque Progression


clinical_trial_age_range: 60 years to 75 years

name: Impact of Oral Ibandronate 150 mg Monthly on Structural Properties of Bone in Postmenopausal Osteoporosis (SPIMOS-3D)


clinical_trial_age_range: 18 years to 65 years

name: Effectiveness of Clonidine, Dexmedetomidine, and Fentanyl Adjuncts for Labor Epidural Analgesia


clinical_trial_age_range: 12 months to 5 years

name: Carbon Dioxide (Carbogen) for the Treatment of Febrile Seizures


clinical_trial_age_range: 18 years or older

name: Capmatinib Plus Trametinib for the Treatment of Metastatic Non-small Cell Lung Cancer With MET Exon 14 Skipping Mutation

original_conditions: Metastatic Lung Non-Small Cell Carcinoma


clinical_trial_age_range: 50 years to 79 years

name: Effect of Evolocumab in Patients at High Cardiovascular Risk Without Prior Myocardial Infarction or Stroke


clinical_trial_age_range: 18 years to 55 years

name: Safety, Tolerability and Pharmacokinetics of ASM-024 Administered to Healthy Subjects and Subjects With Moderate Asthma


name: A Study to Evaluate the Safety and Preliminary Efficacy of a Response-guided Dose Titration of KER-047 in the Treatment of Functional IDA (Iron Deficiency Anemia).


name: Cemiplimab/Peg-Interferon-α in Advanced CSCC


name: A Study Describing Real-World Effectiveness of Nivolumab + Chemotherapy in Neoadjuvant NSCLC


clinical_trial_age_range: 48 hours to 120 days

name: Study to Compare the Efficacy and Safety of Micafungin Versus Conventional Amphotericin B for the Treatment of Neonatal Candidiasis


name: Exemestane With Celecoxib as Neoadjuvant Treatment in Postmenopausal Women With Stage II, III, and IV Breast Cancer


name: Study of of Oxygen Nebulized Inhalation EGCG in Cancer Patients With New Coronary Pneumonia


name: Early Low Dose Steroid Therapy of Acute Respiratory Distress Syndrome

original_conditions:
Acute Lung Injury
Acute Respiratory Distress Syndrome


clinical_trial_age_range: 18 years to 64 years

name: Pre-Emptive Analgesia in Dental Implant Surgery


clinical_trial_age_range: 12 years to 17 years

name: SGLT2 Inhibitors as a Novel Treatment for Pediatric Non-Alcoholic Fatty Liver Disease

original_conditions:
NAFLD
Non-Alcoholic Fatty Liver Disease


name: Efficacy Comparison of Xalatan and Azopt on POAG and OH


name: Safety, Tolerability, and Immunogenicity of Trivalent Coronavirus Vaccine Candidate VBI-2901a


name: Doxorubicin + BIBF 1120 in Patients for Ovarian Cancer

original_interventions:
Doxil
Pegylated Liposomal Doxorubicin


clinical_trial_age_range: 18 years to 70 years

name: The Impact of Arousal Threshold in Obstructive Sleep Apnea


name: Comparing Different Routes and Doses of Phytonadione (Vitamin K) for Reversing Warfarin Treated Patients With Hip Fracture Before Surgery


name: The Effect of Saccharomyces Boulardii in Clinical Presentation and Quality of Life Patient With IBS


clinical_trial_age_range: 40 years or older

name: Study to Evaluate the Safety for the Treatment of Inflammation Associated With Cataract Surgery


name: A Phase II Clinical Trial of PXD101 in Patients With Recurrent or Refractory Cutaneous and Peripheral T-Cell Lymphomas


name: Mesothelin-Targeted Immunotoxin LMB-100 in Combination With Tofacitinib in Persons With Previously Treated Pancreatic Adenocarcinoma, Cholangiocarcinoma and Other Mesothelin Expressing Solid Tumors


name: A Study of CM313 Injection in Subjects With Systemic Lupus Erythematosus


clinical_trial_age_range: 18 years to 100 years

name: Observational Study on the Use of Ropeginterferon Alfa-2b in Polycythemia Vera (ROPEG-PV)


name: Pemetrexed Plus Cisplatin as First-Line Treatment in Stage IV or Recurrence of Gastric Cancer


name: QUILT-3.009: Patients With Stage III (IIIB) or Stage (IV) Merkel Cell Carcinoma (MCC)


name: Study of the Pan-DAC Inhibitor AR-42 and Pazopanib in Advanced Sarcoma and Kidney Cancer


name: A Relative Bioavailability Study Measuring the Extent and Rate of Absorption of Different Tablet Formulations of AZD1656 in Type 2 Diabetes Mellitus (T2DM) Patients


name: Repurposing Metformin As a Leukemia-preventive Drug in CCUS and LR-MDS

original_conditions:
Myelodysplastic Neoplasm
Preleukemia


clinical_trial_age_range: 18 years to 45 years

name: Regulation of KATP Channels and Na+/K+ ATPase in Relation to Fatigue Development


name: Phase III Randomized Trial of Thalidomide/Dexamethasone Versus Vincristine+Adriamycin+Dexamethasone (VAD)


name: Alisertib in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus


clinical_trial_age_range: 21 years to 55 years

name: Behavioral Pharmacology of Orally Administered THC and D-limonene


clinical_trial_age_range: 18 years to 75 years

name: Efficacy, Safety, and Pharmacokinetics of APT-1011 in Subjects With Eosinophilic Esophagitis (EoE)


clinical_trial_age_range: 5 years to 17 years

name: Treatment of Autism in Children and Adolescents


name: Pegylated Interferon and Ribavirin in Hepatitis C Virus Infection After Liver Transplantation.


name: BR101801 in Adult Patients With Advanced Hematologic Malignancies(Phase I)


clinical_trial_age_range: 1 month to 15 years

name: Intranasal Dexmedetomidine Sedation for Pediatric CT Imaging


clinical_trial_age_range: 20 years or older

name: Venous Thromboembolism (VTE) Treatment Study in Japanese Pulmonary Embolism (PE) Patients

original_interventions: BAY59-7939 Rivaroxaban Xarelto


name: Rituximab in Eosinophilic Granulomatosis With Polyangiitis

original_conditions: Eosinophilic Granulomatosis With Polyangiitis (EGPA)


name: Lvosidenib (AK112) Combined With CapeOX and Radiotherapy in Patients With Unresectable Metastatic MSS-type Colorectal Cancer


clinical_trial_age_range: 19 years or older

name: A Phase I Study of ABT 510 for Newly Diagnosed Glioblastoma Multiforme


name: Adj TC + Herceptin Early Stage Breast Cancer


name: Feasibility Study of Chemoradiation, TRAstuzumab and Pertuzumab in Resectable HER2+ Esophageal Carcinoma


name: Feasibility Trial for a Right Ventricular Failure Platform Trial


clinical_trial_age_range: 6 years to 12 years

name: Safety and Efficacy Study of Dexmethylphenidate in Children With ADHD


name: Alisporivir With PEG and RBV in Protease Inhibitor (PI) Treatment Failure Patients With Chronic Hepatitis C


clinical_trial_age_range: 1 year to 80 years

name: Anti-CD19 Chimeric Antigen Receptor (CAR)-Transduced T Cell Therapy for Patients With B Cell Malignancies


clinical_trial_age_range: 18 years or older

name: Study to Assess the Safety of Escalating Doses of AT9283, in Patients With Leukemias


name: A Phase 2 Study to Evaluate Effects of VX-661/Ivacaftor on Lung and Extrapulmonary Systems in Subjects With Cystic Fibrosis, Homozygous for the F508del-CFTR Mutation


clinical_trial_age_range: 18 years to 85 years

name: Memantine Augmentation of Antidepressants


name: Expanded Access Program of Nintedanib in Patients With Idiopathic Pulmonary Fibrosis (EAP)


clinical_trial_age_range: 21 years to 70 years

name: A Study of LY3325656 in Healthy Participants and Participants With Type 2 Diabetes


name: Neoadjuvant Trastuzumab, Pertuzumab and Tucatinib Without Chemotherapy in HER2-positive Breast Cancer: the TRAIN-4 Study


name: Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes

original_conditions:
Diabetes
Diabetes Mellitus, Type 2


clinical_trial_age_range: 16 years or older

name: Pembrolizumab and Hypofractionated Radiation Therapy for the Treatment of Mucosal Melanoma


clinical_trial_age_range: 18 years to 65 years

name: Intralesional Cyclosporine for Alopecia Areata


clinical_trial_age_range: 18 years to 70 years

name: Nonmyeloablative Hematopoietic Cell Transplantation (HCT) for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors: A Pilot Trial of Peripheral Blood Stem Cells (PBSC) as the Donor Source


name: Crizotinib in Lobular Breast, Diffuse Gastric and Triple Negative Lobular Breast Cancer or CDH1-mutated Solid Tumours


name: Vinorelbine Oral Plus Capecitabine Combination In Metastatic Breast Cancer


name: Open-label Study to Evaluate the Safety and Tolerability of iv Lacosamide in Japanese Adults With Partial-onset Seizures


name: Clinical Study of mRNA Vaccine Combined With PD-1 Inhibitor as Adjuvant Therapy for Postoperative Pancreatic Cancer


name: Window Trial of Fluorescently Labeled Panitumumab (Panitumumab-IRDye800) in Head and Neck Cancer


clinical_trial_age_range: 21 years or older

name: Evaluation the Treatment of Tamoxifen of Low/Intermediate Risk Bladder Tumors


name: Comparison of Different Methods to Test MGMT Status in Glioblastoma Patients


name: A Phase 3b Study of Erythropoietin Drugs Using a Specified Dosing Algorithm in Patients With Chronic Kidney Disease on Hemodialysis


name: Bupivacaine HCl PK and Safety in Augmentation Mammoplasty


clinical_trial_age_range: 1 year to 21 years

name: Irinotecan and Cisplatin With or Without Amifostine in Treating Children With Solid Tumors That Have Not Responded to Previous Therapy

original_conditions: Unspecified Childhood Solid Tumor, Protocol Specific


name: EMPAgliflozin in Heart Failure With PReserved Ejection Fraction and End Stage Renal Disease

original_conditions: Heart Failure With Preserved Ejection Fraction


Multimodal Imaging of ECT Effects

clinical_trial_age_range: 25 years to 60 years


clinical_trial_age_range: 9 months to 15 months

name: Growth Hormone Treatment in Infants Aged 1 to 2 Years With Chronic Renal Insufficiency (CRI) and Growth Retardation.

original_conditions:
Chronic Kidney Disease
Chronic Renal Insufficiency


clinical_trial_age_range: 18 years to 75 years

name: Comparator Study of PEG 3350 Versus Prucalopride in Females With Chronic Constipation


name: First Line IRESSA™ Versus Carboplatin/Paclitaxel in Asia


clinical_trial_age_range: 18 years to 80 years

name: Clinical Observation and Mechanism Study of Yunnan Baiyao in Different Stages of Diabetic Foot


name: A Study of LY3022855 in Combination With Durvalumab or Tremelimumab in Participants With Advanced Solid Tumors


clinical_trial_age_range: 6 years or older

name: Expanded Access Program for Aztreonam Lysine for Inhalation in Canadian Patients With Cystic Fibrosis


clinical_trial_age_range: 14 years or older

name: Selinexor in Combination With Ixazomib for the Treatment of Advanced Sarcoma

original_conditions: Malignant Peripheral Nerve Sheath Tumors


clinical_trial_age_range: 18 years to 60 years

name: A Prospective Study of HBV Immunity and HBV Vaccination in Patients With NAFLD in Canada


clinical_trial_age_range: 70 years or older

name: Cabozantinib and Nivolumab Among Older Patients With Renal Cell Carcinoma

original_conditions:
Kidney Cancer
Renal Cell Cancer


clinical_trial_age_range: 18 years to 55 years

name: Study to Evaluate the Safety, Pharmacokinetics and Target Engagement of BMS-986142 in Healthy Subjects


name: PEG-IFN Alfa-2b Plus Ribavirin for Treatment of Mexican naïve Patients With Chronic Hepatitis C Infected With Genotype 1 (Study P04511)(COMPLETED)


clinical_trial_age_range: 18 years or older

name: Study of NM8074 in Patients with Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis (AAV)

original_conditions: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis


name: Study Effects of Ginkgo Biloba Extract on Endothelial Cell Function and Genetic Effects on the Response to Ginkgo Biloba Extract in Diabetic Patients With Stable Coronary Artery Disease


clinical_trial_age_range: 50 years to 70 years

name: Effects of Liraglutide on Hippocampal Structure and Function in Aging Adults With Prediabetes


clinical_trial_age_range: 40 years or older

name: A Randomized, Double-Blind, 4-way Crossover Study to Evaluate the Efficacy of of 24 Hour Spirometry Profiles of Inhaled BI 1744 CL and Inhaled Tiotropium Bromide in Patients With Chronic Obstructive Pulmonary Disease


name: A Study to Evaluate VH4524184 Tablet Absorption, Effects of Food, and Interactions With Other Drugs in Healthy Adults


clinical_trial_age_range: 20 years to 65 years

name: Pegylated Interferon and Entecavir Combination in Chronic Hepatitis B (CHB)


name: Addition of Buprenorphine to Paracervical Block for Pain Control During Osmotic Dilator Insertion


clinical_trial_age_range: 20 years to 40 years

name: Addition of Pyridostigmine to Conventional Management of Postdural Puncture Headache


clinical_trial_age_range: 18 years to 100 years

name: Efficacy, Safety Study and Benefit of Alkali Therapy in Sickle Cell Disease


clinical_trial_age_range: 2 years or older

name: Study of Difluprednate in the Treatment of Inflammation Following Ocular Surgery (ST-601A-002a)


name: Intravenous Ascorbic Acid in Women Receiving Adjuvant or Neo-Adjuvant Chemotherapy for Early Stage Breast Cancer


clinical_trial_age_range: 18 years to 70 years

name: Helicobacter Pylori Eradication With Berberine Quadruple Therapy Versus Clarithromycin Quadruple Therapy


clinical_trial_age_range: 18 years to 65 years

name: Garcinia Mangostana Extracts in the Management of Weight Loss


name: Dalpiciclib Plus AI (Neoadjuvant Endocrine Therapy) Compared With Neoadjuvant Chemotherapy in Early Breast Cancer （EBC）


Clinical Trial of Teriparatide in Japan

clinical_trial_age_range: 55 years or older


clinical_trial_age_range: 19 years to 40 years

name: A Study on Efficacy and Safety of Menopur® Multidose in Korean Female Patients With Infertility


clinical_trial_age_range: 18 years to 85 years

name: Safety and Tolerability of Vildagliptin Versus Placebo in Patients With Type 2 Diabetes and Moderate or Severe Renal Insufficiency (28 Week Extension)


clinical_trial_age_range: 60 years or older

name: Chemotherapy for Participants With Lymphoma


clinical_trial_age_range: up to 29 years

name: Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma

original_conditions:
Adult Alveolar Soft-part Sarcoma
Childhood Alveolar Soft-part Sarcoma

original_conditions: Nonmetastatic Childhood Soft Tissue Sarcoma

original_conditions: Metastatic Childhood Soft Tissue Sarcoma


clinical_trial_age_range: 18 years to 60 years

name: CLAM Chemotherapy With PBSC Support for Relapsed Patients After Allogeneic Stem Cell Transplantation


name: Vascular Function and Biomarker Assessments in Healthy Volunteers and in Patients With Type 2 Diabetes Mellitus


name: A Long-Term Extension Study of WA22762 and NA25220 of Subcutaneous (SC) Tocilizumab (TCZ) in Moderate to Severe Rheumatoid Arthritis (RA)


clinical_trial_age_range: 21 years or older

name: Low Dose of Cannabidiol (CBD) to Treat Mild to Moderate Musculoskeletal Pain


name: Near Normalisation of BG Improves the Potentiating Effect of GLP-1


clinical_trial_age_range: 35 years to 75 years

name: Rapid Effects Linagliptin on Monocyte Polarization and Endothelial Progenitor Cells in Type 2 Diabetes


clinical_trial_age_range: 18 years or older

name: A Study of Galunisertib (LY2157299) in Combination With Nivolumab in Advanced Refractory Solid Tumors and in Recurrent or Refractory NSCLC, or Hepatocellular Carcinoma


name: Comparison of Oral Iron With IV Iron in Patients With Anemia of Chronic Renal Failure Not on Dialysis


name: Impact of Volatile Versus Total Intravenous Anesthesia on Postoperative Delirium in Elderly Diabetic Patients Undergoing Non-Cardiac Surgery: a Multicenter, Randomized Controlled Trial


name: REGN2810 (Anti-PD-1 Antibody), Platinum-based Doublet Chemotherapy, and Ipilimumab (Anti-CTLA-4 Antibody) Versus Pembrolizumab Monotherapy in Patients With Lung Cancer


clinical_trial_age_range: 18 years to 75 years

name: Tucidinostat and Fulvestrant in Hormone-receptor Positive Advanced Breast Cancer


clinical_trial_age_range: 2 years to 17 years

name: An Open-label, Ascending, Repeated Dose-finding Study of Sarilumab in Children and Adolescents With Polyarticular-course Juvenile Idiopathic Arthritis (pcJIA)


name: Pharmacokinetics of Sotorasib in Healthy Participants and Participants With Moderate or Severe Hepatic Impairment


name: Brightline-2: A Study to Test Whether Brigimadlin (BI 907828) Helps People With Cancer in the Biliary Tract, Pancreas, Lung or Bladder


clinical_trial_age_range: 0 hours to 48 hours

name: Pasteurised Donor Human Milk Supplementation for Term Babies


name: Short Life Agents in Balanced Anesthesia on Obstructive Sleep Apnea Syndrome


clinical_trial_age_range: 40 years to 65 years

name: Fludarabine / Total Body Irradiation Regimen for ALLO HCT in Acute Lymphoblastic Leukemia


name: Taxane Therapy With or Without Bavituximab for the Treatment of HER2-Negative Metastatic Breast Cancer


clinical_trial_age_range: 1 month to 24 months

name: Safety, Efficacy and Cost-effectiveness of Racecadotril in Children With Acute Diarrhea in Mexico


clinical_trial_age_range: 18 years to 55 years

name: MMV390048 POC in Patients With P. Vivax and P. Falciparum Malaria


name: Study to Evaluate Adverse Events and Change in Disease Activity With Oral Capsules of Galicaftor/Navocaftor/ABBV-119 or Galicaftor/Navocaftor/ABBV-576 Combination Therapies in Adult Participants With Cystic Fibrosis


clinical_trial_age_range: 40 years to 100 years

name: An Efficacy and Safety Study to Compare Three Doses of BEA 2180 BR to Tiotropium and Placebo in the Respimat Inhaler.


name: Preoperative Hypofractionated Radiotherapy With FOLFOX for Esophageal or Gastroesophageal Junction Adenocarcinoma

original_conditions: Clinical Stage I Esophageal Adenocarcinoma AJCC v8

original_conditions: Clinical Stage II Esophageal Adenocarcinoma AJCC v8

original_conditions: Clinical Stage III Esophageal Adenocarcinoma AJCC v8

original_conditions: Clinical Stage I Gastroesophageal Junction Adenocarcinoma AJCC v8

original_conditions: Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8

original_conditions: Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8


name: A Study Investigate the Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Response of SLN124 in Adults With Alpha/Beta-thalassaemia and Very Low- and Low-risk Myelodysplastic Syndrome


name: Capecitabine, Tucatinib, and Intrathecal Trastuzumab for Breast Cancer Patients With Leptomeningeal Disease


name: A Study of MHB036C for Advanced Solid Tumor


name: Feasibility Study of Unfractionated Heparin in Acute Chest Syndrome


clinical_trial_age_range: any age

name: Regorafenib Post-marketing Surveillance in Japan

original_interventions: Regorafenib Stivarga


name: Study of Intravenous Amino Acid Infusion to Prevent Contrast Dye Mediated Renal Damage


clinical_trial_age_range: 18 years to 70 years

name: Methylprednisolone N Acetylcysteine in Hepatic Resections


name: National Multicenter Trial Evaluating Two Treatments in Patients with Primary Human Immunodeficiency Virus (HIV-1) Infection


name: Assessment of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of APB-R3


name: Acetylcysteine Rinse in Reducing Saliva Thickness and Mucositis in Patients With Head and Neck Cancer Undergoing Radiation Therapy

original_conditions: Stage I Squamous Cell Carcinoma of the Lip and Oral Cavity

original_conditions: Stage I Verrucous Carcinoma of the Oral Cavity

original_conditions: Stage I Mucoepidermoid Carcinoma of the Oral Cavity

original_conditions: Stage I Adenoid Cystic Carcinoma of the Oral Cavity

original_conditions: Stage II Squamous Cell Carcinoma of the Lip and Oral Cavity

original_conditions: Stage II Basal Cell Carcinoma of the Lip

original_conditions: Stage II Verrucous Carcinoma of the Oral Cavity

original_conditions: Stage II Mucoepidermoid Carcinoma of the Oral Cavity

original_conditions: Stage II Adenoid Cystic Carcinoma of the Oral Cavity

original_conditions: Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity

original_conditions: Stage III Basal Cell Carcinoma of the Lip

original_conditions: Stage III Verrucous Carcinoma of the Oral Cavity

original_conditions: Stage III Mucoepidermoid Carcinoma of the Oral Cavity

original_conditions: Stage III Adenoid Cystic Carcinoma of the Oral Cavity

original_conditions: Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity

original_conditions: Recurrent Basal Cell Carcinoma of the Lip

original_conditions: Recurrent Verrucous Carcinoma of the Oral Cavity

original_conditions: Recurrent Mucoepidermoid Carcinoma of the Oral Cavity

original_conditions: Recurrent Adenoid Cystic Carcinoma of the Oral Cavity

original_conditions: Stage I Squamous Cell Carcinoma of the Oropharynx

original_conditions: Stage I Lymphoepithelioma of the Oropharynx

original_conditions: Stage II Squamous Cell Carcinoma of the Oropharynx

original_conditions: Stage II Lymphoepithelioma of the Oropharynx

original_conditions: Stage III Squamous Cell Carcinoma of the Oropharynx

original_conditions: Stage III Lymphoepithelioma of the Oropharynx

original_conditions: Recurrent Squamous Cell Carcinoma of the Oropharynx

original_conditions: Recurrent Lymphoepithelioma of the Oropharynx

original_conditions: Stage I Squamous Cell Carcinoma of the Nasopharynx

original_conditions: Stage I Lymphoepithelioma of the Nasopharynx

original_conditions: Stage II Squamous Cell Carcinoma of the Nasopharynx

original_conditions: Stage II Lymphoepithelioma of the Nasopharynx

original_conditions: Stage III Squamous Cell Carcinoma of the Nasopharynx

original_conditions: Stage III Lymphoepithelioma of the Nasopharynx

original_conditions: Stage IV Squamous Cell Carcinoma of the Nasopharynx

original_conditions: Stage IV Lymphoepithelioma of the Nasopharynx

original_conditions: Recurrent Squamous Cell Carcinoma of the Nasopharynx

original_conditions: Recurrent Lymphoepithelioma of the Nasopharynx

original_conditions: Stage I Squamous Cell Carcinoma of the Larynx

original_conditions: Stage I Verrucous Carcinoma of the Larynx

original_conditions: Stage II Squamous Cell Carcinoma of the Larynx

original_conditions: Stage II Verrucous Carcinoma of the Larynx

original_conditions: Stage III Squamous Cell Carcinoma of the Larynx

original_conditions: Stage III Verrucous Carcinoma of the Larynx

original_conditions: Recurrent Squamous Cell Carcinoma of the Larynx

original_conditions: Recurrent Verrucous Carcinoma of the Larynx

original_conditions: Stage IVA Basal Cell Carcinoma of the Lip

original_conditions: Stage IVA Squamous Cell Carcinoma of the Larynx

original_conditions: Stage IVA Verrucous Carcinoma of the Larynx

original_conditions: Stage IVA Adenoid Cystic Carcinoma of the Oral Cavity

original_conditions: Stage IVA Mucoepidermoid Carcinoma of the Oral Cavity

original_conditions: Stage IVA Verrucous Carcinoma of the Oral Cavity

original_conditions: Stage IVA Squamous Cell Carcinoma of the Oropharynx

original_conditions: Stage IVB Basal Cell Carcinoma of the Lip

original_conditions: Stage IVB Squamous Cell Carcinoma of the Larynx

original_conditions: Stage IVB Verrucous Carcinoma of the Larynx

original_conditions: Stage IVB Adenoid Cystic Carcinoma of the Oral Cavity

original_conditions: Stage IVB Mucoepidermoid Carcinoma of the Oral Cavity

original_conditions: Stage IVB Verrucous Carcinoma of the Oral Cavity

original_conditions: Stage IVB Squamous Cell Carcinoma of the Oropharynx

original_conditions: Stage IVC Basal Cell Carcinoma of the Lip

original_conditions: Stage IVC Squamous Cell Carcinoma of the Larynx

original_conditions: Stage IVC Verrucous Carcinoma of the Larynx

original_conditions: Stage IVC Adenoid Cystic Carcinoma of the Oral Cavity

original_conditions: Stage IVC Mucoepidermoid Carcinoma of the Oral Cavity

original_conditions: Stage IVC Verrucous Carcinoma of the Oral Cavity

original_conditions: Stage IVC Squamous Cell Carcinoma of the Oropharynx

original_conditions: Stage IVA Squamous Cell Carcinoma of the Lip and Oral Cavity

original_conditions: Stage IVB Squamous Cell Carcinoma of the Lip and Oral Cavity

original_conditions: Stage IVC Squamous Cell Carcinoma of the Lip and Oral Cavity

original_conditions: Stage IVB Lymphoepithelioma of the Oropharynx

original_conditions: Stage IVA Lymphoepithelioma of the Oropharynx

original_conditions: Stage IVC Lymphoepithelioma of the Oropharynx


name: Neoadjuvant Chemotherapy With Gemcitabine Plus Cisplatin Followed by Radical Liver Resection Versus Immediate Radical Liver Resection Alone With or Without Adjuvant Chemotherapy in Incidentally Detected Gallbladder Carcinoma After Simple Cholecystectomy or in Front of Radical Resection of BTC


clinical_trial_age_range: 18 years to 65 years

name: Dose-Ranging Study of Sofosbuvir in Combination With Pegylated Interferon and Ribavirin in Treatment Naïve GT 1 HCV Patients


clinical_trial_age_range: 35 years or older

name: Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade Lesions

original_conditions: High-grade Squamous Intraepithelial Lesion


clinical_trial_age_range: 6 years to 17 years

name: A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata


name: A Study In Patients Who Will Undergo Surgical Removal Of Non-Small Cell Lung Cancer To Evaluate Molecular Changes That Occur In Tumor Tissue After Short Term Exposure To PF-00299804


name: Injection Of AJCC Stage IIB, IIC, III And IV Melanoma Patients With A Multi-Epitope Peptide Vaccine Using GM-CSF DNA As An Adjuvant: A Pilot Trial To Assess Safety And Immunity


name: Study of Lacutamab in Peripheral T-cell Lymphoma


name: Phase 2 Trial of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab in Patients With Newly Diagnosed PD-L1 CPS Positive Resectable Stage 3-4 Oral Cavity Squamous Cell Carcinoma (OCSCC).


name: QUILT 3.071: NANT Colorectal Cancer (CRC) Vaccine


name: A Study Evaluating the Safety, Efficacy and Pharmacokinetics of Venetoclax Combined With Chemotherapy in Participants With B-Cell Non-Hodgkin's Lymphoma (NHL) and DLBCL


name: Evaluation of Triple Therapy Using Magnetic Resonance Imaging in Asthma


clinical_trial_age_range: 18 years to 40 years

name: Dexmedetomidine Wound Infiltration in Cesarean Section


name: Study to Evaluate the Safety and Tolerability of Weekly Intravenous (IV) Doses of BMS-906024 in Subjects With Acute T-cell Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma

original_conditions:
Lymphoblastic Leukemia, Acute T-cell
Precursor T-Cell Lymphoblastic Lymphoma


name: Safety Study of MGAH22 in HER2-positive Carcinomas


name: Multicenter Clinical Trial of Intravenous OvaRex MAb-B43.13 as Post-Chemotherapy Consolidation for Ovarian Carcinoma


MPN-RC 118 AVID200 in Myelofibrosis

original_conditions:
Post PV MF
Post-polycythemia Vera Myelofibrosis


name: A Study of ASP8302 in Participants With Underactive Bladder


name: A Phase II Study of Axicabtagene Ciloleucel, an Anti-CD19 Chimeric Antigen Receptor (CAR) Tcell Therapy, in Combination With Radiotherapy (RT) in Relapsed/Refractory Follicular Lymphoma


name: Sildenafil to Reduce Vascular Remodeling During Left Ventricular Assist Device Support


name: A Survey on Quetiapine Extended-release Tablets in Patients With Depression in Bipolar Disorder


name: Duloxetine for Postoperative Pain of Laparoscopic Cholecystectomy


clinical_trial_age_range: 60 years to 80 years

name: Ischaemia-réperfusion During the Coronary Surgery With Beating Heart

original_interventions: Diltiazem diltiazem


name: Safety and Efficacy of Switching From a Stimulant Medication to Atomoxetine in Children and Adolescents With ADHD

original_conditions: Attention Deficit Hyperactivity Disorder


clinical_trial_age_range: 18 years to 99 years

name: Oral Tranexamic Acid vs. Oral Aminocaproic Acid to Reduce Blood Loss After Total Hip Replacement


name: AGuIX Nanoparticles With Radiotherapy Plus Concomitant Temozolomide in the Treatment of Newly Diagnosed Glioblastoma


name: A Safety Study of SGN-CD33A in AML Patients

original_conditions:
Acute Myelogenous Leukemia
Acute Myeloid Leukemia


name: Biweekly Avastin and Docetaxel as the First Line Treatment for Patients With Metastatic Breast Cancer


clinical_trial_age_range: 18 years to 45 years

name: A Pharmacokinetic Evaluation of Etonogestrel (ENG) Implant and Antiretroviral Therapy


name: IV Plerixafor With Mitoxantrone Etoposide and Cytarabine for Acute Myeloid Leukemia (AML)


name: The Efficacy of Thyme Honey Mouth Rinse on Polypharmacy-induced Xerostomia


clinical_trial_age_range: 18 years or older

name: The Effect of Neoadjuvant DMPA on Glandular Cellularity in Women Awaiting Hysterectomy

original_conditions: Complex Atypical Endometrial Hyperplasia

original_conditions: Grade 1 Endometrial Endometrioid Adenocarcinoma

original_conditions: Grade 2 Endometrial Endometrioid Adenocarcinoma


name: The Comparison Study of Intralesional Botulinum Toxin A and Corticosteroid Injection for Alopecia Areata


name: Dissecting the Role of Estradiol in Mediating Gender-specific Anxiolytic and Prosocial Effects of Oxytocin


name: NaF Positron Emission Tomography/Computed Tomography (PET/CT)Imaging to Assess Treatment Responsiveness to TAK-700 in Patients With Castrate Resistant Prostate Cancer (CRPC) With Bone Metastasis

original_conditions:
Prostate Cancer
Prostatic Neoplasms


name: Study of MCLA-129 in the Treatment of Advanced Non-small Cell Lung Cancer with AGA and MET Amplification.


name: Fish Oil in pREgnancY for Personalized Prevention of Early Childhood Asthma


clinical_trial_age_range: 2 years to 5 years

name: Safety and Tolerability of Ciclesonide Nasal Spray in Patients With Perennial Allergic Rhinitis (2-5 Years Old) (BY9010/M1-416)

original_conditions:
Hay Fever
Perennial Allergic Rhinitis


name: An Exploratory Psoriasis Plaque Test Study With Different Dose Combinations of Calcipotriol Plus Betamethasone Dipropionate in the Daivobet® Gel Vehicle in Psoriasis Vulgaris


clinical_trial_age_range: 18 years to 80 years

name: Comparison Between Cisatracurium and Rocuronium in Terms of Recovery of the Muscular Strength in the Postoperative Phase After Surgery and General Anaesthesia

original_conditions:
Postoperative Residual Curarization
Residual Neuromuscular Block


clinical_trial_age_range: 18 years to 75 years

name: Long-term Efficacy and Safety of HMS5552 in T2DM Subjects


name: Liposomal Bupivacaine in Benign Soft Tissue Tumor Resection


clinical_trial_age_range: 18 years to 100 years

name: PANVAC-V and PANVAC-F Vaccines Plus Sargramostim to Treat Advanced Cancer

original_interventions: GM-CSF Sargramostim


name: Peri-Procedural Myocardial Infarction, Platelet Reactivity, Thrombin Generation, and Clot Strength: Differential Effects of Eptifibatide + Bivalirudin Versus Bivalirudin


name: Post-operative Radiation With Cetuximab for Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck


clinical_trial_age_range: 1 month to 16 years

name: Non Inferiority KawasakI Trial With Anakinra


name: Study BT5528-100 in Patients With Advanced Solid Tumors Associated With EphA2 Expression


name: BMN 673 (Talazoparib), an Oral PARP Inhibitor, in People With Deleterious BRCA1/2 Mutation-Associated Ovarian Cancer Who Have Had Prior PARP Inhibitor Treatment


name: The Safety and Effectiveness of Surgery With or Without Raloxifene for the Treatment of Pelvic Pain Caused by Endometriosis


name: Prophylactic Antimicrobial Catheter Lock


name: A Study Evaluating the Safety and Efficacy of Cobimetinib Plus Atezolizumab in BRAFV600 Wild-type Melanoma With Central Nervous System Metastases and Cobimetinib Plus Atezolizumab and Vemurafenib in BRAFV600 Mutation-positive Melanoma With Central Nervous System Metastases


name: Study of Itraconazole in Patients With Advanced HIV Infection


name: Normal Oxygenation Versus Hyperoxia in the Intensive Care Unit (ICU)


name: A Study to Investigate the Pharmacokinetics and ECG Effects of Linaprazan Glurate


name: SBRT, Chemotherapy, and AK104 Neoadjuvant Therapy for Triple-negative Breast Cancer (TNBC)


name: A Study to Evaluate the Effect of HER2 Activation on rhuMAb 2C4 (Pertuzumab) in Subjects With Advanced Ovarian Cancer


clinical_trial_age_range: 31 years to 59 years

name: Neuronal Correlates of Neurexan® Action in Mildly to Moderately Stressed Probands


clinical_trial_age_range: 18 years to 30 years

name: PrEP With TDF/FTC to Prevent HIV-1 Acquisition in Young MSM and Transgender Women of Color


clinical_trial_age_range: 14 years to 61 years

name: Effect of Lugol's Solution in the Patients With Graves' Disease


clinical_trial_age_range: 16 years to 60 years

name: Total Marrow and Lymphoid Irradiation Before Donor Transplant and Cyclophosphamide in Treating Patients With Acute Myeloid Leukemia


clinical_trial_age_range: 18 years to 65 years

name: Topiramate Treatment of Hazardous and Harmful Alcohol Use in Veterans With TBI


clinical_trial_age_range: 16 years to 40 years

name: The Effect of Different Remineralizing Agents on White Spot Lesions and Dental Plaque During Orthodontic Retention


clinical_trial_age_range: 18 years to 90 years

name: Safety and Efficacy of IV CXA-101 and IV Ceftazidime in Patients With Complicated Urinary Tract Infections


name: Melatonin and Cardiac Outcome After Major Surgery


clinical_trial_age_range: 18 years to 70 years

name: Novel CAR-T Cell Therapy in the Treatment of Hematopoietic and Lymphoid Malignancies


name: A Trial to Assess Cobicistat Boosted Venetoclax in Combination With Azacitidine in Adult Patients With Newly Diagnosed AML


name: Comparison of Brivanib and Best Supportive Care (BSC) With Placebo and BSC for Treatment of Liver Cancer in Asian Patients Who Have Failed Sorafenib Treatment


name: Impact of Reactogenicity of the 2024-2025 COVID-19 Vaccines on Health Care Workers and First Responders in the United States


name: Application of Intraoperative Transesophageal Echocardiography Imaging of Vein and CLCVP in Early Prediction and Intervention CSA-AKI


clinical_trial_age_range: 20 years or older

name: A Phase II Study of Weekly Genexol-PM in Patients With Hepatocelluar Carcinoma After Failure of Sorafenib


clinical_trial_age_range: 6 months to 19 years

name: Prevention of Febrile Neutropenia by Synbiotics in Pediatric Cancer Patients


name: Phase II Study of Ibrutinib in Advanced Carcinoid and Pancreatic Neuroendocrine Tumors


name: MEDICO-ECONOMIC EVALUATION OF SURGERY GUIDED BY FLUORESCENCE FOR THE OPTIMIZATION OF RESECTION OF GLIOBLASTOMAS


clinical_trial_age_range: 18 years to 40 years

name: Norepinephrine Infusion Different Doses in Cesarean Delivery


clinical_trial_age_range: 18 years or older

name: Study of HCD122 in Adults With Non-Hodgkin's or Hodgkin's Lymphoma Who Have Progressed After at Least Two Prior Therapies


clinical_trial_age_range: 3 years to 16 years

name: Ibuprofen Versus Codeine. Is One Better for Post-operative Pain Relief Following Reduction of Paediatric Forearm Fractures?


name: Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer

original_conditions: Anatomic Stage III Breast Cancer AJCC v8

original_conditions: Hormone Receptor-Positive Breast Carcinoma


clinical_trial_age_range: 1 year to 6 years

name: FSME IMMUN NEW Follow-up to Study 199 in Children Aged 1 to 6 Years


name: Study of QLH12016 in Combination With Novel Hormonal Agent in Subjects With Advanced Prostate Cancer


clinical_trial_age_range: 18 years to 80 years

name: The Effect of Ribose on B-Type Natriuretic Peptide (BNP) Levels in Congestive Heart Failure Patients


name: Study of Copanlisib in Combination With Standard Immunochemotherapy in Relapsed Indolent Non-Hodgkin's Lymphoma (iNHL)


clinical_trial_age_range: 40 years or older

name: A Study to Assess Cardiovascular Outcomes Following Treatment With Omarigliptin (MK-3102) in Participants With Type 2 Diabetes Mellitus (MK-3102-018)


name: Study to Evaluate Efficacy, Safety and Biomarkers of Bulevirtide Treatment in Chronic Hepatitis D Patients


clinical_trial_age_range: 19 years or older

name: Dabrafenib Plus Trametinib in Patients With Advanced Solid Tumor Having BRAF V600E Mutation or Clinically Actionable BRAF Gene Alterations


clinical_trial_age_range: 16 years to 70 years

name: Preoperative Dose of Co-amoxiclav for Prevention of Postoperative Complications in Dentoalveolar Surgery


name: TDF VS LAM + ADV in LAM + ADV Treated LAM-resistant CHB Patients With Undetectable Hepatitis B Virus DNA


clinical_trial_age_range: 12 years to 35 years

name: Photoactive Porphyrins (PAP) Levels After Topical Visonac Application in Acne Patients


name: NOV120101 Phase 2 Study in NSCLC Patients With Aquired Resistance to 1st Generation EGFR Tyrosine Kinase Inhibitors


clinical_trial_age_range: 20 years to 80 years

name: Intraoperative IV Iron on Postoperative Red Blood Cell Recovery


name: Safety and Efficacy of PF-299804 (Dacomitinib), a Pan-HER Irreversible Inhibitor, in Patients With Recurrent Glioblastoma With EGFR Amplification or Presence of EGFRvIII Mutation. A Phase II CT.


name: Study of RTXM83 Plus CHOP Chemotherapy Versus a Rituximab Plus CHOP Therapy in Patients With Non Hodgkin's Lymphoma


name: BACE Trial Substudy 1 - PROactive Substudy


name: The Influence of Local Antibiotic Therapy on the Outcomes Following Periodontal Regeneration Procedures.


clinical_trial_age_range: 18 years to 60 years

name: Phase 2 Clinical Trial to Evaluate the Safety and Efficacy of Plasmid DNA Therapeutic Vaccine(GX-188E)


name: suPAR-guided Anakinra Treatment for Validation of the Risk and Management of Respiratory Failure by COVID-19 (SAVE)


clinical_trial_age_range: 60 years to 90 years

name: AZA Combined with R-GemOx for Elderly DLBCL Patients


name: Talazoparib for Cohesin-Mutated AML and MDS With Excess Blasts


clinical_trial_age_range: 18 years to 65 years

name: Sensitization Study of ATx201 in Healthy Volunteers


clinical_trial_age_range: 12 years or older

name: Nivolumab, Fluorouracil, and Interferon Alpha 2B for the Treatment of Unresectable Fibrolamellar Cancer

original_interventions: Recombinant Interferon Alpha 2b-like Protein

original_conditions: Stage III Hepatocellular Carcinoma AJCC v8

original_conditions: Stage IIIA Hepatocellular Carcinoma AJCC v8

original_conditions: Stage IIIB Hepatocellular Carcinoma AJCC v8

original_conditions: Stage IV Hepatocellular Carcinoma AJCC v8

original_conditions: Stage IVA Hepatocellular Carcinoma AJCC v8

original_conditions: Stage IVB Hepatocellular Carcinoma AJCC v8


clinical_trial_age_range: 60 years or older

name: The Addition of Hydromorphone to Local Anesthetics for the Repair of Inguinal Hernias in Elderly Patients


name: Mechanisms of Sleep Latency and Health: The Effect of a Melatonin Receptor Agonist in Inflammation and Insulin Resistance


name: HEALEY ALS Platform Trial - Regimen C CNM-Au8


clinical_trial_age_range: 2 years to 18 years

name: Population Pharmacokinetics of Terbinafine in Children With Tinea Capitis


name: Effect of Bitter in Overweight Female Volunteers


clinical_trial_age_range: 20 years to 40 years

name: Dermatopharmacokinetic Trial of LEO 80185 Gel


clinical_trial_age_range: 2 years or older

name: A Pilot Study of Fludarabine Plus Cyclophosphamide in Refractory Severe Aplastic Anemia


clinical_trial_age_range: 18 years or older

name: Milrinone Versus Dobutamine in Critically Ill Patients


name: ExIST Study of LY2157299 (Galunisertib) in Rectal Cancer


clinical_trial_age_range: 18 years to 42 years

name: GnRH Agonist and Progesterone Versus Progesterone Only for Luteal Phase Support in Antagonist Cycles


name: Cinacalcet Study to Reach Kidney Disease Outcomes Quality Initiative (K/DOQI) Levels


name: Efficacy of SGLT2 Inhibitors in Adults With Sepsis


name: A 12-Week Study to Evaluate the Efficacy of Darifenacin to Increase the Warning Time in Patients With Overactive Bladder.


clinical_trial_age_range: 19 years to 55 years

name: A Study to Examine the Effects of Entinostat on Midazolam in Healthy Adult Subjects


name: Anesthesia for Obese Patients: Desflurane Versus Xenon


name: Study of AK119 in Subjects With Advanced Solid Tumors


name: PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma

original_conditions:
Bile Duct Cancer
Cholangiocarcinoma


name: A Clinical Trial of Natalizumab in Individuals With Moderately to Severely Active Crohn's Disease


name: Follow up Protocol to the Phase I/II Study of OPN-305 in Second-line or Third-line Lower Lower Risk Myelodysplastic Syndrome


clinical_trial_age_range: 6 years to 12 years

name: A Pivotal Efficacy Trial to Evaluate HLD200 in Children With ADHD in a Naturalistic Setting

original_conditions: Attention Deficit Hyperactivity Disorder


clinical_trial_age_range: 18 years to 70 years

name: Study of Daclatasvir (BMS-790052) Add-on to Standard of Care in Treatment- naïve Patients


name: INCB106385 Alone or in Combination With Immunotherapy in Advanced Solid Tumors

original_conditions: Squamous Cell Carcinoma of Head and Neck


clinical_trial_age_range: 35 years to 70 years

name: A Multicenter, Double-blind Study to Evaluate the Effect of Pretreatment With a Daily Dose of Sildenafil on the As-Needed Efficacy of Viagra in Men With Erectile Dysfunction and Type 2 Diabetes


name: Neoadjuvant Chemotherapy in Patients With Intermediate Risk Upper and Mid Rectal Cancer

original_conditions:
Rectal Cancer
Rectum Carcinoma


name: Cisplatin vs. Doxorubicin/Cyclophosphamide in BrCa


name: The Effect of Supplementation of Flaxseed, Hesperidin, Flaxseed and Hesperidin Together in Metabolic Syndrome


clinical_trial_age_range: 19 years or older

name: VELCADE®-BEAM and Autologous Hematopoietic Stem Cell Transplantation for Non-Hodgkin's Lymphoma, or Mantle Cell Lymphoma

original_interventions: BCNU carmustine


name: Rituximab and Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With B-Cell Non-Hodgkin's Lymphoma


name: Study of Zanubrutinib, Obinutuzumab, and Venetoclax in Patients With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL)


clinical_trial_age_range: 3 years to 11 years

name: Study of Infigratinib in Children With Achondroplasia


clinical_trial_age_range: 20 years to 70 years

name: A Study of LY3437943 in Participants With Type 2 Diabetes Mellitus (T2DM)


name: Lenalidomide Plus Melphalan as a Preparative Regimen for Autologous Stem Cell Transplantation in Relapsed Multiple Myeloma: A Phase 1 / 2 Study


clinical_trial_age_range: 18 years to 80 years

name: Free-residue Nutrients for the Bowel Preparation of Colon Capsule Endoscopy


name: The Use of Allogenic Platelet Rich Plasma for the Treatment of Diabetic Foot Ulcer


name: Safety and Tolerability of Pembrolizumab (MK-3475) + Pegylated Interferon Alfa-2b and Pembrolizumab+ Ipilimumab in Participants With Advanced Melanoma or Renal Cell Carcinoma (MK-3475-029/KEYNOTE-29)


name: Fluticasone and Salmeterol in Allergic Rhinitis


name: Tinzaparin for Primary Treatment and Extended Secondary Prophylaxis of Venous Thromboembolism in Patients With Cancer


name: Propolis-based Product (FARINGEL PLUS) for Oral Mucositis in Palliative Care


clinical_trial_age_range: 18 years to 64 years

name: Mechanisms of N-acetylcysteine Mediated Vascular Adverse Effects


clinical_trial_age_range: 35 years or older

name: RCT on the Efficacy of Methotrexate for the Prevention of GTD


Vitamin D to ENhance TraUma REcovery

clinical_trial_age_range: 18 years to 65 years


Benfotiamine in Diabetic Nephropathy

clinical_trial_age_range: 40 years to 75 years


name: HAI-Floxuridine, or Liver-Tx, Combined With 2nd Line Chemotherapy Versus 2nd Line Chemotherapy Alone for Patients With Colorectal Liver Metastases and Heavy Tumour Burden.


clinical_trial_age_range: 12 years or older

name: A Collaborative Double-Blind Placebo-Controlled Trial of Intravenous Ribavirin As a Treatment for Presumed Hantavirus Pulmonary Syndrome


name: An Observational Study of Avastin in Participants With Metastatic Colorectal Cancer (KORALLE)


clinical_trial_age_range: 18 years to 75 years

name: Anlotinib Combined With Docetaxel for Advanced Non-Small Cell Lung Cancer（ALTER-L034）


clinical_trial_age_range: 18 years to 130 years

name: A Study of Durvalumab Alone and Durvalumab+Olaparib in Advanced, Platinum-Ineligible Bladder Cancer (BAYOU)


clinical_trial_age_range: 18 years to 60 years

name: Role of Microglial Activation and Norepinephrine Transporter Abnormalities in Pathogenesis of MS-related Fatigue


clinical_trial_age_range: 18 years or older

name: Pemigatinib for FGF/FGFR Alterations Advanced Pan Solid Tumors


clinical_trial_age_range: 40 years or older

name: Atorvastatin Calcium, Oligofructose-Enriched Inulin, or Sulindac in Preventing Cancer in Patients at Increased Risk of Developing Colorectal Neoplasia


clinical_trial_age_range: any age

name: PROSTACOX : Metastatic Prostate Chemotherapy


name: Neoadjuvant Colorectal Cancer With Unresectable Liver Metastases


name: TRIMBOW® and RELVAR® on Lung Stiffness Reduction Assessed Through Forced Oscillation Technique in Patients With COPD


name: Clinical Trial to Evaluation the Safety and Efficacy of GR-MD-02 for the Treatment of Liver Fibrosis and Resultant Portal Hypertension in Patients With Nash Cirrhosis


clinical_trial_age_range: 18 years to 100 years

name: Gemcitabine, Oxaliplatin and Panitumumab in Kras/B-raf Wild-Type Biliary Track and Gallbladder Cancer


clinical_trial_age_range: up to 6 months

name: Use of Hyperpolarized 129Xe MR Lung Imaging in Infants


name: The Analgesic Efficacy of Two Bupivacaine Concentrations for Combined Ilioinguinal and Iliohypogastric Nerve Block in Postherniorrhaphy Pain


name: An Effectiveness and Safety Study of PF-04383119 for the Treatment of Pain in Interstitial Cystitis


name: A Continuation Trial for Subjects With Lupus Who Completed Protocol HGS1006-C1056 in the United States


name: Methenamine Hippurate Following Intradetrusor OnabotulinumtoxinA Injection


name: A Trial of KB004 in Patients With Glioblastoma


name: Testing the Feasibility of Patient Controlled Sedation for Ventilated ICU Patients


name: Intratumoral Vusolimogene Oderparepvec (VO) in Combination With Pembrolizumab for Angiosarcoma

original_conditions:
Angiosarcoma
Angiosarcoma, Adult


clinical_trial_age_range: 18 years to 45 years

name: Citalopram and Self Emotional Processing

original_conditions:
Depression
Depressive Disorder


name: SU5416 and Carboplatin to Treat Ovarian Cancer


clinical_trial_age_range: 18 years to 70 years

name: Evaluation of Tofacitinib in Early Diffuse Cutaneous Systemic Sclerosis (dcSSc)

original_conditions:
Scleroderma
Systemic Sclerosis


name: Ph II Study of Enfortumab Vedotin in Patients With Advanced or Metastatic CRC or HCC


name: A Phase I/IIa Open-Label, Dose Escalation and Cohort Expansion Trial of Oral TSR-011 in Patients With Advanced Solid Tumors and Lymphomas


clinical_trial_age_range: 18 years to 30 years

name: Investigating the Acute and Chronic Effects of an American Ginseng Root Extract on Cognition and Mood


name: Pivotal Study in HER2 Negative, Locally Recurrent or Metastatic Breast Cancer


name: A Phase 2 Study to Evaluate the Efficacy and Safety of SAR444656 Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa


name: Efficacy Study of Additional Chemotherapy After Concurrent Chemoradiation in Non-small Cell Lung Cancer


clinical_trial_age_range: 21 years or older

name: Hexadecasaccharide (SR123781A) in Patients With Unstable Angina or Non-ST-Segment Elevation Myocardial Infarction


name: Auranofin and Sirolimus in Treating Patients With Advanced Solid Tumors or Recurrent Non-Small Cell Lung Cancer

original_conditions: Unspecified Adult Solid Tumor, Protocol Specific


clinical_trial_age_range: 7 years to 13 years

name: Somatropin Treatment to Final Height in Turner Syndrome


Dasotraline Binge Eating Disorder Study

clinical_trial_age_range: 18 years to 55 years


clinical_trial_age_range: 20 years or older

name: Tenofovir Alafenamide Versus Entecavir for the Treatment of Chronic Hepatitis B


name: Benzac 5% Gel in Combination With Cosmetic Products in Acne Vulgaris


name: Study of Cadonilimab Combined With Bevacizumab and Chemotherapy for Advanced Nonsquamous Non-small Cell Lung Cancer Patients With Untreated Brain Metastases


name: Bevacizumab in Patients With Severe Covid-19


clinical_trial_age_range: up to 5 years

name: A Study to Inv. Safety, Efficacy & PD of Dasiglucagon as Hypoglycemia Rescue Therapy in Children <6 Years With T1D


clinical_trial_age_range: 18 years to 62 years

name: Studying Different Formulations of SR13668 in Healthy Volunteers


clinical_trial_age_range: 7 years or older

name: RESULT: Reliable, Emergent Solution Using Liprotamase Treatment


name: A Study to Assess the Safety and Pharmacokinetics of GDC-8264 in Combination With Standard of Care in Participants With Acute Graft-Versus-Host Disease (aGVHD)


clinical_trial_age_range: 30 years to 65 years

name: Safety, Tolerability, Immunological and Clinical Efficacy of Multiple Subcutaneous Doses of DiaPep277 in Latent Autoimmune Diabetes in Adults (LADA)


name: Effect Of Different Lining Materials in Stepwise Excavation


clinical_trial_age_range: 18 years to 60 years

name: The Effect of Arsenic Trioxide on Eliminating HIV-1 Reservoir Combined With cART


clinical_trial_age_range: 18 years or older

name: Abatacept for Treatment of Recurrent or de Novo Autoimmune Hepatitis


clinical_trial_age_range: 75 years to 94 years

name: The Effect and Safety of Different Intensity Anticoagulation Therapy in Elderly Patients With Non-valvular Atrial Fibrillation


clinical_trial_age_range: 12 years to 24 years

name: Study to Compare the Pharmacokinetics of Fixed-Dose Combination of Mometasone + Azelastine Nasal Spray to Mometasone and Azelastine Nasal Sprays in Adolescents and Young Adults With Seasonal Allergic Rhinitis

original_interventions:
Azelastine
Azelastine Hydrochloride

original_interventions:
Mometasone
Mometasone Furoate


name: Neoadjuvant Zoledronate and Atorvastatin in Triple Negative Breast Cancer


clinical_trial_age_range: 55 years or older

name: A Study of REC-4881 in Participants with Cancers Which Have an AXIN1 or APC Mutation


clinical_trial_age_range: 19 years to 120 years

name: Paclitaxel, Cyclophosphamide & Doxorubicin, Autologous Dendritic Cells & Surgery in Stage II/III Breast Cancer (Women)


name: The Combination of Anlotinib and Immune Checkpoint Inhibitors for Advanced NSCLC Patients With Muti-line Therapy


clinical_trial_age_range: 18 years to 65 years

name: A Study to Investigate the Safety and Pharmacokinetics of a Single Dose of VH3810109 (Also Known as GSK3810109), Administered Either Subcutaneously (SC) With rHuPH20 or Intravenously (IV), in Healthy Adult Participants


name: Insulin Detemir Compared to Insulin Glargine: Appetite and Calories Consumed in Type 1 Diabetes

original_interventions:
Insulin Detemir
Insulin Glargine


clinical_trial_age_range: 18 years to 50 years

name: Efficacy of Ramelteon on Insomnia Symptoms Associated With Jet Lag in Healthy Adult Volunteers


name: A Study of Selinexor in Combination With Standard of Care Therapy for Newly Diagnosed or Recurrent Glioblastoma


name: Comparison of Two Insulin Degludec Formulations in Subjects With Type 2 Diabetes Mellitus

original_conditions:
Diabetes
Diabetes Mellitus, Type 2


name: A Study to Evaluate the Tolerance, Pharmacokinetics and Efficacy of TQ-A3334 Tablets


clinical_trial_age_range: any age

name: Prevention of Liver Damage During Liver Surgery


Pravastatin to Prevent Preeclampsia

clinical_trial_age_range: 16 years or older


name: A Pilot Study of Triple NtRTI/NsRTI Therapy in Antiretroviral Naive HIV-1 Infected Patients


name: Docetaxel and S-1 for Advanced Esophageal Cancer


name: Axitinib Intensification Plus Nivolumab or Nivolumab Alone After Nivolumab Plus Ipilimumab in mRCC Patients


clinical_trial_age_range: 20 years to 75 years

name: Efficacy Study of Vortioxetine (Lu AA21004) for Treatment of Major Depressive Disorder


name: Taribavirin Phase 2 Dose Finding Study for the Treatment of Hepatitis C Virus (HCV)


name: BI-1910 as a Single Agent and in Combination With Pembrolizumab for the Treatment of Advanced Solid Tumors


name: Analgesic Effect of Preoperative Dexamethasone in Gynecological Laparotomies - a Dose-ranging Study


name: Safety, Tolerability, and Efficacy of mFOLFIRINOX ± BNT321 as Adjuvant Therapy Following Curative Resection in Patients With Pancreatic Adenocarcinoma


clinical_trial_age_range: 18 years to 75 years

name: The Efficacy and Safety of TACE, Lenvatinib and Camrelizumab in the Treatment of BCLC Stage B/C Hepatocellular Carcinoma: a Single-arm, Single-center, Open-label Study


clinical_trial_age_range: 20 years or older

name: A Study of Combination with TBI-1401(HF10) and Ipilimumab in Japanese Patients with Unresectable or Metastatic Melanoma


name: Abraxane and Alimta in Advanced Solid Tumors


clinical_trial_age_range: 18 years to 80 years

name: Thalidomide and Rituximab in Waldenstrom's Macroglobulinemia

original_conditions:
Lymphoplasmacytic Lymphoma
Waldenstrom's Macroglobulinemia


clinical_trial_age_range: 20 years to 40 years

name: Effect of Liraglutide in Obese Women With Polycystic Ovary Syndrome


name: Bioequivalence Study of Crushed Sofosbuvir/Velpatasvir Compared to the Whole Tablet


name: Phase II Randomized Trial of the Combination of Cetuximab and Sorafenib or Single Agent Cetuximab

original_conditions: Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma

original_conditions: Untreated Metastatic Squamous Neck Cancer With Occult Primary

original_conditions: Recurrent Metastatic Squamous Neck Cancer With Occult Primary

original_conditions: Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity

original_conditions: Recurrent Verrucous Carcinoma of the Oral Cavity

original_conditions: Recurrent Squamous Cell Carcinoma of the Oropharynx

original_conditions: Stage IV Squamous Cell Carcinoma of the Nasopharynx

original_conditions: Recurrent Squamous Cell Carcinoma of the Nasopharynx

original_conditions: Stage IV Squamous Cell Carcinoma of the Hypopharynx

original_conditions: Recurrent Squamous Cell Carcinoma of the Hypopharynx

original_conditions: Recurrent Squamous Cell Carcinoma of the Larynx

original_conditions: Recurrent Verrucous Carcinoma of the Larynx

original_conditions: Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity

original_conditions: Stage IVA Squamous Cell Carcinoma of the Larynx

original_conditions: Stage IVA Verrucous Carcinoma of the Larynx

original_conditions: Stage IVA Verrucous Carcinoma of the Oral Cavity

original_conditions: Stage IVA Squamous Cell Carcinoma of the Oropharynx

original_conditions: Stage IVB Squamous Cell Carcinoma of the Larynx

original_conditions: Stage IVB Verrucous Carcinoma of the Larynx

original_conditions: Stage IVB Verrucous Carcinoma of the Oral Cavity

original_conditions: Stage IVB Squamous Cell Carcinoma of the Oropharynx

original_conditions: Stage IVC Squamous Cell Carcinoma of the Larynx

original_conditions: Stage IVC Verrucous Carcinoma of the Larynx

original_conditions: Stage IVC Verrucous Carcinoma of the Oral Cavity

original_conditions: Stage IVC Squamous Cell Carcinoma of the Oropharynx

original_conditions: Stage IVA Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity

original_conditions: Stage IVC Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity

original_conditions: Stage IVB Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity

original_conditions: Stage IVA Squamous Cell Carcinoma of the Lip and Oral Cavity

original_conditions: Stage IVB Squamous Cell Carcinoma of the Lip and Oral Cavity

original_conditions: Stage IVC Squamous Cell Carcinoma of the Lip and Oral Cavity


clinical_trial_age_range: 50 years or older

name: Open-Label Extension of the PTI-125-04 Study in Mild-to-Moderate Alzheimer's Disease


name: IO Combined With AI as First-line Treatment for Patients With Soft Tissue Sarcoma(TAIS)

original_conditions: Malignant Peripheral Nerve Sheath Tumor (MPNST)


name: MEK Inhibitor PD-325901 To Treat Advanced Breast Cancer, Colon Cancer, And Melanoma.


name: Comparative Study of Dorzol Eye Drops, 20 mg/ml Versus Trusopt® Eye Drops, 20 mg/ml

original_conditions: Primary Open Angle Glaucoma of Both Eyes


name: Estramustine, Docetaxel and Zoledronate Treatment in Hormone-Refractory Adenocarcinoma of the Prostate


name: Comparison of Assisted Reproductive Technology (ART) Outcomes Between Two Protocols of Induction of Ovulation in Patients With Hypogonadotropic Hypogonadism


clinical_trial_age_range: 18 years to 55 years

name: Forced-dose Titration of SPD489 in Adults With Binge Eating Disorder


name: Study of a Single Administration of 3 Doses of Dysport® for the Treatment of Benign Essential Blepharospasm


name: EP0057 in Combination With Olaparib in Advanced Ovarian Cancer


clinical_trial_age_range: 18 years to 60 years

name: Glucagon-like Peptide-1 Receptor Agnoists for the Assessment of Adrenal Function


clinical_trial_age_range: 18 years or older

name: Effects of Raltegravir Based Regimen on Platelet Reactivity, Platelet-monocyte Aggregation and Immune Activation


clinical_trial_age_range: 18 years to 70 years

name: DARWIN Study: A Randomization/Withdrawal Efficacy Study of Dexloxiglumide in Constipation-Predominant Irritable Bowel Syndrome (C-IBS)


name: A Dose Escalation and Dose Expansion Study of NOX66 in the Treatment of COVID-19


name: Study of the Safety and Immunogenicity of Pfs230D1M-EPA/Alhydrogel and Pfs25M-EPA/Alhydrogel , a Transmission Blocking Vaccine Against Plasmodium Falciparum Malaria, in Adults in the U.S. and Mali


name: Phase I Dose Escalation Study of Intravenously Administered S64315 in Combination With Orally Administered Venetoclax in Patients With Acute Myeloid Leukaemia.


clinical_trial_age_range: 18 years to 35 years

name: Amelioration of Polycystic Ovary Syndrome Related Disorders by Supplementation of Thymoquinone and Metformin

original_interventions: TQ Thymoquinone


name: TK216 and Decitabine in Treating Patients With Relapsed and Refractory Acute Myeloid Leukemia


clinical_trial_age_range: 21 years to 65 years

name: Testing Mestinon and Exercise in Fibromyalgia


name: Sotorasib Combined With First-line Chemotherapy for Advanced Pancreatic Adenocarcinoma


name: Vasopressin and Pain Perception in the Brain


clinical_trial_age_range: 17 years or older

name: Milk-derived Gangliosides for Inflammatory Bowel Disease


clinical_trial_age_range: 25 years or older

name: IRX-2 Regimen in Treating Women With Cervical Squamous Intraepithelial Neoplasia 3 or Squamous Vulvar Intraepithelial Neoplasia 3

original_conditions: Vulvar High Grade Squamous Intraepithelial Lesion

original_conditions: Cervical Squamous Cell Carcinoma In Situ


name: Study to Investigate the Management of Hypertension and Efficacy of AZD2171 in Patients With Advanced Solid Tumours


Alpha and Omega of Lifestyle Therapy

clinical_trial_age_range: 30 years to 60 years


name: Pembrolizumab and Vorinostat in Treating Patients With Recurrent Squamous Cell Head and Neck Cancer or Salivary Gland Cancer That Is Metastatic and/or Cannot Be Removed by Surgery

original_conditions: Squamous Cell Carcinoma Metastatic in the Neck With Occult Primary

original_conditions: Recurrent Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma

original_conditions: Stage IVA Major Salivary Gland Carcinoma

original_conditions: Stage IVB Major Salivary Gland Carcinoma

original_conditions: Stage IVC Major Salivary Gland Carcinoma

original_conditions: Stage IVC Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma

original_conditions: Stage IVB Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma

original_conditions: Stage IVA Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma

original_conditions: Stage III Major Salivary Gland Carcinoma

original_conditions: Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma


name: Safety and Efficacy of Gadobutrol 1.0 Molar (Gadavist) in Patients for Central Nervous System (CNS) Imaging

original_interventions: Gadavist Gadobutrol

original_interventions: Gadoteridol ProHance


name: A Phase 1 Study of FOR46 in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)


clinical_trial_age_range: 1 year to 17 years

name: Bosutinib in Pediatric Patients With Newly Diagnosed Chronic Phase or Resistant/Intolerant Ph + Chronic Myeloid Leukemia

original_conditions: Blastic Phase Chronic Myelogenous Leukemia

original_conditions: Accelerated Phase Chronic Myelogenous Leukemia

original_conditions: Chronic Phase Chronic Myelogenous Leukemia


clinical_trial_age_range: 20 years to 80 years

name: The Effect of Atorvastatin on Prevention of Postoperative Acute Kidney Injury in Patients Undergoing Aortic Surgery


clinical_trial_age_range: 50 years to 85 years

name: Molecular Imaging of Inflammation in Parkinson's Disease Using LPS and TSPO-PET/MR


clinical_trial_age_range: 18 years to 65 years

name: Cardiovascular Effects of GLP-1 Receptor Activation


clinical_trial_age_range: 18 years to 99 years

name: PF-00299804 As A Single Agent, In Patients With Advanced Non-Small Cell Lung Cancer Who Have Failed Chemotherapy And Erlotinib


name: Ferinject® Assessment in Patients With Iron Deficiency and Chronic Heart Failure (FAIR-HF)

original_conditions:
Iron Deficiency
Iron Deficiency Anemia


clinical_trial_age_range: 2 years or older

name: Nuclear Imaging of Human CSF Flow Using Ga-67 Citrate and In-111 DTPA


clinical_trial_age_range: up to 25 years

name: Phase II Open Label Trial to Determine Safety & Efficacy of Tisagenlecleucel in Pediatric Non-Hodgkin Lymphoma Patients